| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 1.48e-07 | 5 | 264 | 4 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 4.39e-07 | 6 | 264 | 4 | GO:0016160 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TBL1Y MED14 FADD KDM3B DAXX ZZEF1 TRRAP KMT2C FZR1 JUP TELO2 ARID5B TAB1 BAIAP2 GNB1 SETD3 MED26 PIH1D1 WNK3 RAD17 NCOA2 CASP8AP2 ZCCHC12 UBQLN2 ARID3A BTAF1 ECPAS CRKL KLHL22 NCOR1 KMT2D SETD5 ATF7IP PDE4DIP ALYREF SSX3 HERPUD1 TP53BP1 | 9.13e-06 | 1356 | 264 | 38 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TBL1Y MED14 FADD KDM3B DAXX ZZEF1 TRRAP KMT2C FZR1 JUP ARID5B BAIAP2 GNB1 SETD3 MED26 PIH1D1 WNK3 RAD17 NCOA2 CASP8AP2 ZCCHC12 UBQLN2 ARID3A BTAF1 CRKL KLHL22 NCOR1 KMT2D SETD5 ATF7IP ALYREF SSX3 HERPUD1 TP53BP1 | 1.13e-05 | 1160 | 264 | 34 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | TBL1Y MED14 KDM3B DAXX TRRAP KMT2C JUP ARID5B SETD3 MED26 NCOA2 CASP8AP2 ZCCHC12 ARID3A BTAF1 NCOR1 KMT2D SETD5 ATF7IP SSX3 TP53BP1 | 2.03e-05 | 562 | 264 | 21 | GO:0003712 |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 2.24e-05 | 5 | 264 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 4.44e-05 | 6 | 264 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | chloride ion binding | 4.80e-05 | 16 | 264 | 4 | GO:0031404 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 4.80e-05 | 16 | 264 | 4 | GO:0008179 | |
| GeneOntologyMolecularFunction | chromatin binding | TBL1Y ZFP57 KDM3B MEIS3 BCL6 CIC MEIS1 PHF21A DDX11 SUPT6H MITF RAD17 MPO NCOA2 DDX12P ARID3A EP400 AIRE CHD8 ADNP PHC1 NCOR1 SMC3 ANKRD17 | 5.01e-05 | 739 | 264 | 24 | GO:0003682 |
| GeneOntologyMolecularFunction | histone binding | TBL1Y DAXX ZZEF1 BPTF SUPT6H PIH1D1 PHIP IPO7 AIRE CHD8 PHC1 SETD5 TP53BP1 | 5.54e-05 | 265 | 264 | 13 | GO:0042393 |
| GeneOntologyMolecularFunction | protein binding involved in heterotypic cell-cell adhesion | 7.90e-05 | 18 | 264 | 4 | GO:0086080 | |
| GeneOntologyMolecularFunction | thiosulfate transmembrane transporter activity | 1.74e-04 | 2 | 264 | 2 | GO:0015117 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 1.81e-04 | 9 | 264 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.09e-04 | 188 | 264 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 2.56e-04 | 10 | 264 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | calcium ion binding | ZZEF1 TENM2 RYR1 MYL6B CACNA1B HSPG2 AMY1A AMY1B AMY1C AMY2B CALM1 CALM2 CALM3 PCLO EFEMP2 CPS1 CUBN EYS HMCN1 LRP2 LRP4 CDH7 | 4.21e-04 | 749 | 264 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 4.33e-04 | 206 | 264 | 10 | GO:0140030 | |
| GeneOntologyMolecularFunction | malate transmembrane transporter activity | 5.18e-04 | 3 | 264 | 2 | GO:0015140 | |
| GeneOntologyMolecularFunction | oxaloacetate transmembrane transporter activity | 5.18e-04 | 3 | 264 | 2 | GO:0015131 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 5.92e-04 | 13 | 264 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | titin binding | 7.47e-04 | 14 | 264 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.88e-04 | 118 | 264 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.03e-03 | 4 | 264 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | EXOC3 ARFIP2 TENM2 SIRPG JUP GPNMB BAIAP2 CD200R1L COL5A1 NRCAM TNC PKP4 LAMA5 CRKL USO1 CTNNA1 PCBP1 CDH7 | 1.08e-03 | 599 | 264 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 1.13e-03 | 16 | 264 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 1.27e-03 | 61 | 264 | 5 | GO:0098632 | |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 1.35e-03 | 17 | 264 | 3 | GO:0001161 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 1.35e-03 | 17 | 264 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GPAA1 MYO5B DLGAP5 ZNF207 DAXX MAST2 DLC1 GNB1 SETD3 CAP2 KRT2 KIF6 KRT10 CALM1 NRCAM CALM2 CALM3 ADNP SPAG6 LMOD3 HOOK3 FEZ1 SMC3 SBDS MYO1F CTNNA1 MYO15A | 1.47e-03 | 1099 | 264 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.52e-03 | 127 | 264 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 1.61e-03 | 18 | 264 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 2.06e-03 | 41 | 264 | 4 | GO:0140463 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.21e-03 | 20 | 264 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 2.21e-03 | 20 | 264 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | MED14 DAXX TRRAP KMT2C JUP ARID5B SETD3 MED26 NCOA2 ZCCHC12 KMT2D | 2.44e-03 | 303 | 264 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | succinate transmembrane transporter activity | 2.52e-03 | 6 | 264 | 2 | GO:0015141 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.65e-03 | 262 | 264 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.68e-03 | 44 | 264 | 4 | GO:0140938 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 2.00e-06 | 3 | 261 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | head development | EPHB2 EPHB3 NR2C2 RELN MEIS3 PLXNB2 CIC MEIS1 BPTF DLC1 ARID5B EEF1AKMT4-ECE2 HSPG2 CALM1 NRCAM CALM2 SZT2 CALM3 CHD8 SPAG6 CRKL TIPARP NCOR1 HOOK3 WDR11 FEZ1 ZIC5 DOCK7 LRP2 NRG3 | 2.07e-06 | 919 | 261 | 30 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 2.67e-06 | 32 | 261 | 6 | GO:0010800 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TET2 DLGAP5 ZFP57 MED14 KDM3B DAXX BCL6 ZZEF1 TRRAP EMSY PHF21A DDX11 BPTF KMT2C SUPT6H SETD3 MED26 PIH1D1 RAD17 EP400 CHD8 BTAF1 HUWE1 PHC1 NCOR1 KMT2D SETD5 ATF7IP CHTOP TP53BP1 | 1.07e-05 | 999 | 261 | 30 | GO:0071824 |
| GeneOntologyBiologicalProcess | brain development | EPHB2 EPHB3 NR2C2 RELN MEIS3 PLXNB2 CIC MEIS1 BPTF DLC1 EEF1AKMT4-ECE2 HSPG2 CALM1 NRCAM CALM2 SZT2 CALM3 CHD8 SPAG6 CRKL NCOR1 HOOK3 FEZ1 ZIC5 DOCK7 LRP2 NRG3 | 1.37e-05 | 859 | 261 | 27 | GO:0007420 |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 1.97e-05 | 5 | 261 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | chromatin organization | TET2 ZFP57 KDM3B DAXX BCL6 ZZEF1 TRRAP EMSY PHF21A DDX11 BPTF KMT2C SUPT6H SETD3 PIH1D1 RAD17 EP400 CHD8 BTAF1 HUWE1 PHC1 NCOR1 KMT2D SETD5 ATF7IP CHTOP TP53BP1 | 2.87e-05 | 896 | 261 | 27 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 3.89e-05 | 6 | 261 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 3.89e-05 | 6 | 261 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 4.84e-05 | 52 | 261 | 6 | GO:0010799 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TET2 NR2C2 HIVEP1 TBL1Y MED14 FADD DAXX MEIS3 DCN MEIS1 BPTF KMT2C JUP GABPB2 SUPT6H PKD1 MITF NFYA SETD3 MED26 PHIP NCOA2 ZCCHC12 ARID3A FOSB AIRE CHD8 HEYL KMT2D USF3 EAF1 MTF1 PCBP1 NPAS4 TP53BP1 | 7.72e-05 | 1390 | 261 | 35 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 1.07e-04 | 8 | 261 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.59e-04 | 9 | 261 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | endocytic hemoglobin import into cell | 1.60e-04 | 2 | 261 | 2 | GO:0020028 | |
| GeneOntologyBiologicalProcess | thiosulfate transport | 1.60e-04 | 2 | 261 | 2 | GO:0015709 | |
| GeneOntologyBiologicalProcess | synapse assembly | EPHB2 EPHB3 RELN PLXNB2 NRCAM PCLO ADNP CRKL SETD5 DOCK7 LRP4 NRG3 NPAS4 | 1.62e-04 | 308 | 261 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | axon development | EPHB2 EPHB3 RELN MYO5B LAMA1 PLXNB2 TENM2 PLPPR4 BAIAP2 HSPG2 NRCAM SZT2 TNC LAMA5 ADNP FEZ1 DOCK7 LRP2 LRP4 CTNNA1 | 2.09e-04 | 642 | 261 | 20 | GO:0061564 |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.14e-05 | 85 | 262 | 8 | GO:0000118 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ELOA2 TBL1Y UBQLN4 MED14 KDM3B TRRAP PHF21A DDX11 BPTF KMT2C FZR1 JUP CPSF4 SUPT6H NFYA MED26 SAP130 INTS6L NCOA2 DDX12P GNL3L IPO7 EP400 CHD8 NUP214 ADNP PRPF8 PHC1 NCOR1 KMT2D EAF1 SETD5 DOCK7 ALYREF DHX32 CHTOP | 2.27e-05 | 1377 | 262 | 36 | GO:0140513 |
| GeneOntologyCellularComponent | basement membrane | 1.54e-04 | 122 | 262 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | migrasome | 1.55e-04 | 9 | 262 | 3 | GO:0140494 | |
| GeneOntologyCellularComponent | spindle pole | 2.75e-04 | 205 | 262 | 10 | GO:0000922 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.09e-04 | 73 | 262 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 3.40e-04 | 137 | 262 | 8 | GO:0019897 | |
| MousePheno | embryonic lethality during organogenesis | SP2 NR2C2 ELOA2 FADD DAXX F5 MEIS1 DDX11 BPTF FZR1 JUP DLC1 TELO2 PKD1 BAIAP2 RAD17 COL5A1 HSPG2 DDX12P ARID3A EP400 EFEMP2 CHD8 HUWE1 REV3L CUBN ANGPTL6 KMT2D SETD5 ANKRD17 | 1.08e-05 | 876 | 204 | 30 | MP:0006207 |
| MousePheno | abnormal embryonic tissue morphology | SP2 ELOA2 FADD DAXX PLXNB2 TRRAP F5 DDX11 BPTF DLC1 PKD1 ARHGAP29 CC2D2A GNB1 RAD17 DDX12P ARID3A EP400 LAMA5 CHD8 HUWE1 REV3L CUBN ADNP CRKL WDR11 ZIC5 SETD5 SBDS LRP2 LRP4 ANKRD17 CTNNA1 CHTOP | 3.07e-05 | 1116 | 204 | 34 | MP:0002085 |
| MousePheno | abnormal jaw morphology | MEIS3 DCN ZZEF1 WIZ PKD1 ARID5B MITF HSPG2 LAMA5 CRKL TIPARP CNNM4 ZDHHC20 KMT2D KLK4 WDR11 ZIC5 SETD5 LRP2 LRP4 CHTOP | 3.22e-05 | 530 | 204 | 21 | MP:0000454 |
| MousePheno | abnormal craniofacial morphology | FGFR1OP2 KDM3B MEIS3 DCN ZZEF1 RYR1 DLC1 WIZ PKD1 ARID5B MITF ARHGAP29 CC2D2A BAIAP2 GNB1 PHIP RAD17 KRT2 HSPG2 KIF6 KRT10 LAMA5 SIK3 REV3L PHC1 CRKL TIPARP CNNM4 ZDHHC20 KMT2D KLK4 WDR11 SMC3 MTF1 ZIC5 SETD5 LRP2 LRP4 CHTOP | 3.52e-05 | 1372 | 204 | 39 | MP:0000428 |
| MousePheno | craniofacial phenotype | FGFR1OP2 KDM3B MEIS3 DCN ZZEF1 RYR1 DLC1 WIZ PKD1 ARID5B MITF ARHGAP29 CC2D2A BAIAP2 GNB1 PHIP RAD17 KRT2 HSPG2 KIF6 KRT10 LAMA5 SIK3 REV3L PHC1 CRKL TIPARP CNNM4 ZDHHC20 KMT2D KLK4 WDR11 SMC3 MTF1 ZIC5 SETD5 LRP2 LRP4 CHTOP | 3.52e-05 | 1372 | 204 | 39 | MP:0005382 |
| MousePheno | abnormal cranium morphology | MEIS3 DCN ZZEF1 RYR1 WIZ PKD1 ARID5B MITF BAIAP2 PHIP HSPG2 KIF6 LAMA5 SIK3 PHC1 CRKL TIPARP CNNM4 ZDHHC20 KMT2D KLK4 WDR11 ZIC5 SETD5 LRP2 LRP4 CHTOP | 5.29e-05 | 813 | 204 | 27 | MP:0000438 |
| MousePheno | abnormal viscerocranium morphology | MEIS3 DCN ZZEF1 WIZ PKD1 ARID5B MITF HSPG2 LAMA5 SIK3 CRKL TIPARP CNNM4 ZDHHC20 KMT2D KLK4 WDR11 ZIC5 SETD5 LRP2 LRP4 CHTOP | 5.58e-05 | 593 | 204 | 22 | MP:0005274 |
| MousePheno | lethality throughout fetal growth and development | SP2 ZFP57 MEIS1 RYR1 JUP WIZ PKD1 CC2D2A TAB1 GNB1 LAMA5 CRKL NCOR1 WDR11 MTF1 SETD5 SBDS CHTOP | 6.98e-05 | 435 | 204 | 18 | MP:0006208 |
| MousePheno | increased exploration in new environment | 6.98e-05 | 150 | 204 | 10 | MP:0001415 | |
| MousePheno | abnormal craniofacial bone morphology | MEIS3 DCN ZZEF1 RYR1 WIZ PKD1 ARID5B MITF BAIAP2 PHIP HSPG2 KIF6 LAMA5 SIK3 PHC1 CRKL TIPARP CNNM4 ZDHHC20 KMT2D KLK4 WDR11 ZIC5 SETD5 LRP2 LRP4 CHTOP | 7.07e-05 | 827 | 204 | 27 | MP:0002116 |
| MousePheno | decreased circulating triiodothyronine level | 1.15e-04 | 18 | 204 | 4 | MP:0005479 | |
| MousePheno | abnormal aorta morphology | PKD1 TAB1 SAP130 COL5A1 HSPG2 EFEMP2 LAMA5 WDR27 CRKL SETD5 LRP2 CHTOP | 1.16e-04 | 225 | 204 | 12 | MP:0000272 |
| MousePheno | abnormal mouth morphology | FGFR1OP2 MEIS3 DCN ZZEF1 RYR1 WIZ ARID5B MITF ARHGAP29 CC2D2A HSPG2 LAMA5 PHC1 CRKL TIPARP CNNM4 ZDHHC20 KLK4 WDR11 ZIC5 SETD5 LRP2 LRP4 | 1.21e-04 | 670 | 204 | 23 | MP:0000452 |
| MousePheno | dilated third ventricle | 1.24e-04 | 34 | 204 | 5 | MP:0000827 | |
| MousePheno | abnormal neural tube morphology | SP2 ELOA2 FADD PLXNB2 DDX11 DLC1 PKD1 CC2D2A GNB1 RAD17 DDX12P EP400 LAMA5 REV3L ADNP CRKL WDR11 ZIC5 LRP2 ANKRD17 CHTOP | 1.52e-04 | 591 | 204 | 21 | MP:0002151 |
| MousePheno | abnormal cardiac outflow tract development | 1.52e-04 | 134 | 204 | 9 | MP:0006126 | |
| MousePheno | increased allantois apoptosis | 1.62e-04 | 8 | 204 | 3 | MP:0003891 | |
| MousePheno | abnormal head morphology | FGFR1OP2 KDM3B MEIS3 DCN ZZEF1 RYR1 WIZ ARID5B MITF ARHGAP29 CC2D2A GNB1 KRT2 HSPG2 KRT10 LAMA5 CHD8 BTAF1 HUWE1 SPAG6 PHC1 CRKL TIPARP CNNM4 ZDHHC20 KMT2D KLK4 WDR11 ZIC5 SETD5 LRP2 LRP4 | 1.80e-04 | 1120 | 204 | 32 | MP:0000432 |
| MousePheno | abnormal heart and great artery attachment | PKD1 CC2D2A TAB1 HSPG2 LAMA5 PHC1 CRKL WDR11 SETD5 LRP2 CHTOP | 2.13e-04 | 205 | 204 | 11 | MP:0010426 |
| MousePheno | abnormal heart ventricle morphology | ELOA2 FADD BCL6 MEIS1 RYR1 JUP DLC1 PKD1 CC2D2A TAB1 BAIAP2 SAP130 CAP2 HSPG2 LAMA5 WDR27 PRPF8 PHC1 CRKL NCOR1 WDR11 SETD5 LRP2 ANKRD17 CHTOP | 2.30e-04 | 793 | 204 | 25 | MP:0005294 |
| MousePheno | abnormal heart and great vessel attachment | PKD1 CC2D2A TAB1 HSPG2 LAMA5 PHC1 CRKL WDR11 SETD5 LRP2 CHTOP | 2.41e-04 | 208 | 204 | 11 | MP:0010425 |
| MousePheno | abnormal axial skeleton morphology | PABPC4 KDM3B TIMM23 MEIS3 DCN ZZEF1 EMSY RYR1 ANKRD18B PRKD3 BPTF WIZ PKD1 ARID5B MITF TAB1 BAIAP2 SETD3 PHIP HSPG2 KIF6 TIMM23B LAMA5 SIK3 PHC1 CRKL TIPARP CNNM4 ZDHHC20 ZNF106 KMT2D KLK4 WDR11 ZIC5 SETD5 LRP2 LRP4 CHTOP | 2.77e-04 | 1458 | 204 | 38 | MP:0002114 |
| MousePheno | hemorrhage | SP2 LRSAM1 FADD KDM3B F5 MEIS1 JUP PKD1 CC2D2A TAB1 BAIAP2 RAD17 HSPG2 KIF6 ARID3A SZT2 MAP3K8 EFEMP2 TIPARP SETD5 ANKRD17 CHTOP | 2.82e-04 | 664 | 204 | 22 | MP:0001914 |
| MousePheno | decreased triiodothyronine level | 3.14e-04 | 23 | 204 | 4 | MP:0005473 | |
| MousePheno | abnormal extraembryonic tissue morphology | FGFR1OP2 LAMA1 DAXX TRRAP F5 DDX11 BPTF FZR1 JUP DLC1 PKD1 BAIAP2 NCOA2 COL5A1 DDX12P ARID3A LAMA5 REV3L CUBN CRKL ANGPTL6 SETD5 SBDS LRP2 ANKRD17 CTNNA1 CHTOP | 3.26e-04 | 908 | 204 | 27 | MP:0002086 |
| Domain | Growth_fac_rcpt_ | EPHB2 EPHB3 LAMA1 HSPG2 TNC EFEMP2 LAMA5 CUBN EYS HMCN1 LRP2 LRP4 | 1.60e-06 | 156 | 255 | 12 | IPR009030 |
| Domain | EGF_2 | EPHB2 RELN LAMA1 TENM2 HSPG2 TNC EFEMP2 LAMA5 CUBN EYS HMCN1 WIF1 LRP2 LRP4 NRG3 | 3.88e-06 | 265 | 255 | 15 | PS01186 |
| Domain | EGF | RELN LAMA1 TENM2 HSPG2 TNC EFEMP2 LAMA5 CUBN EYS HMCN1 WIF1 LRP2 LRP4 NRG3 | 4.55e-06 | 235 | 255 | 14 | SM00181 |
| Domain | EGF-like_dom | RELN LAMA1 TENM2 HSPG2 TNC EFEMP2 LAMA5 CUBN EYS HMCN1 WIF1 LRP2 LRP4 NRG3 | 8.84e-06 | 249 | 255 | 14 | IPR000742 |
| Domain | Alpha_amylase | 9.96e-06 | 4 | 255 | 3 | IPR006046 | |
| Domain | Aamy_C | 9.96e-06 | 4 | 255 | 3 | SM00632 | |
| Domain | EGF_1 | RELN LAMA1 TENM2 HSPG2 TNC EFEMP2 LAMA5 CUBN EYS HMCN1 WIF1 LRP2 LRP4 NRG3 | 1.16e-05 | 255 | 255 | 14 | PS00022 |
| Domain | EGF-like_CS | RELN LAMA1 TENM2 HSPG2 TNC EFEMP2 LAMA5 CUBN EYS HMCN1 WIF1 LRP2 LRP4 NRG3 | 1.50e-05 | 261 | 255 | 14 | IPR013032 |
| Domain | Laminin_G_2 | 1.59e-05 | 40 | 255 | 6 | PF02210 | |
| Domain | Alpha-amylase_C | 2.46e-05 | 5 | 255 | 3 | PF02806 | |
| Domain | A-amylase/branching_C | 2.46e-05 | 5 | 255 | 3 | IPR006048 | |
| Domain | LamG | 2.79e-05 | 44 | 255 | 6 | SM00282 | |
| Domain | EGF | 5.88e-05 | 126 | 255 | 9 | PF00008 | |
| Domain | Alpha-amylase | 8.45e-05 | 7 | 255 | 3 | PF00128 | |
| Domain | Glyco_hydro_13_cat_dom | 8.45e-05 | 7 | 255 | 3 | IPR006047 | |
| Domain | Aamy | 8.45e-05 | 7 | 255 | 3 | SM00642 | |
| Domain | EGF_3 | RELN TENM2 HSPG2 TNC EFEMP2 CUBN EYS HMCN1 WIF1 LRP2 LRP4 NRG3 | 9.82e-05 | 235 | 255 | 12 | PS50026 |
| Domain | Laminin_IV | 1.34e-04 | 8 | 255 | 3 | IPR000034 | |
| Domain | LAMININ_IVA | 1.34e-04 | 8 | 255 | 3 | PS51115 | |
| Domain | Laminin_B | 1.34e-04 | 8 | 255 | 3 | PF00052 | |
| Domain | LamB | 1.34e-04 | 8 | 255 | 3 | SM00281 | |
| Domain | Laminin_G | 1.36e-04 | 58 | 255 | 6 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 1.58e-04 | 38 | 255 | 5 | PS50025 | |
| Domain | FoP_C | 1.86e-04 | 2 | 255 | 2 | IPR025715 | |
| Domain | FoP_duplication | 1.86e-04 | 2 | 255 | 2 | SM01218 | |
| Domain | FoP_duplication | 1.86e-04 | 2 | 255 | 2 | PF13865 | |
| Domain | ARM_REPEAT | 2.03e-04 | 40 | 255 | 5 | PS50176 | |
| Domain | EGF_CA | 2.73e-04 | 122 | 255 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.05e-04 | 124 | 255 | 8 | IPR001881 | |
| Domain | ARM-like | DAXX TRRAP JUP TELO2 IPO7 DOCK8 PKP4 BTAF1 HUWE1 ARMCX5 ECPAS SPAG6 | 3.55e-04 | 270 | 255 | 12 | IPR011989 |
| Domain | Ephrin_rec_like | 3.83e-04 | 11 | 255 | 3 | PF07699 | |
| Domain | Laminin_G_1 | 3.83e-04 | 11 | 255 | 3 | PF00054 | |
| Domain | cEGF | 4.00e-04 | 26 | 255 | 4 | PF12662 | |
| Domain | cEGF | 4.00e-04 | 26 | 255 | 4 | IPR026823 | |
| Domain | Armadillo | 4.38e-04 | 47 | 255 | 5 | IPR000225 | |
| Domain | A-amylase_C | 5.52e-04 | 3 | 255 | 2 | IPR031319 | |
| Domain | ARM-type_fold | TRRAP JUP TELO2 UBQLN2 IPO7 DOCK8 PKP4 BTAF1 HUWE1 ARMCX5 ECPAS SPAG6 USO1 | 8.21e-04 | 339 | 255 | 13 | IPR016024 |
| Domain | Glyco_hydro_b | 1.01e-03 | 15 | 255 | 3 | IPR013780 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.13e-07 | 11 | 196 | 5 | M47958 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 4.32e-06 | 9 | 196 | 4 | M47622 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.02e-05 | 76 | 196 | 8 | M27219 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.11e-05 | 11 | 196 | 4 | M1091 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.01e-05 | 41 | 196 | 6 | M27778 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.59e-05 | 5 | 196 | 3 | MM14493 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 5.13e-05 | 6 | 196 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 5.13e-05 | 6 | 196 | 3 | MM15662 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 5.30e-05 | 30 | 196 | 5 | MM15170 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 8.89e-05 | 7 | 196 | 3 | MM1357 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.63e-04 | 59 | 196 | 6 | M27218 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.65e-04 | 84 | 196 | 7 | M7098 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 2.09e-04 | 9 | 196 | 3 | M3412 | |
| Pathway | REACTOME_DIGESTION | 2.61e-04 | 23 | 196 | 4 | M27790 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 2.96e-04 | 10 | 196 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 2.96e-04 | 10 | 196 | 3 | M47954 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 4.02e-04 | 11 | 196 | 3 | MM14810 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 4.26e-04 | 26 | 196 | 4 | MM1431 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | KDM3B TRRAP PHF21A KMT2C ARID5B SETD3 SAP130 NCOA2 EP400 NCOR1 KMT2D ATF7IP | 4.28e-04 | 272 | 196 | 12 | M29619 |
| Pathway | BIOCARTA_PYK2_PATHWAY | 4.95e-04 | 27 | 196 | 4 | M7739 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 5.31e-04 | 12 | 196 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 5.31e-04 | 12 | 196 | 3 | MM15142 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORTERS | 5.31e-04 | 12 | 196 | 3 | M27350 | |
| Pathway | REACTOME_ORGANIC_ANION_TRANSPORTERS | 5.31e-04 | 12 | 196 | 3 | MM15087 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 5.31e-04 | 12 | 196 | 3 | M47956 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 5.71e-04 | 28 | 196 | 4 | M27837 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 6.56e-04 | 29 | 196 | 4 | MM15219 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 6.83e-04 | 13 | 196 | 3 | MM15078 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.48e-04 | 30 | 196 | 4 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 7.48e-04 | 30 | 196 | 4 | MM15517 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 8.01e-04 | 79 | 196 | 6 | M27643 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 8.14e-04 | 109 | 196 | 7 | MM15074 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 8.50e-04 | 31 | 196 | 4 | MM14896 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 8.60e-04 | 14 | 196 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 8.60e-04 | 14 | 196 | 3 | M47388 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 8.60e-04 | 14 | 196 | 3 | MM15052 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 8.60e-04 | 14 | 196 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 8.60e-04 | 14 | 196 | 3 | MM15391 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 9.61e-04 | 32 | 196 | 4 | MM15143 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 9.77e-04 | 55 | 196 | 5 | M27001 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.06e-03 | 15 | 196 | 3 | M47385 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.06e-03 | 15 | 196 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 1.06e-03 | 15 | 196 | 3 | MM14795 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 1.06e-03 | 15 | 196 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 1.06e-03 | 15 | 196 | 3 | MM15103 | |
| Pubmed | TET2 NR2C2 HIVEP1 ACACB UBQLN4 CIC PHF21A JUP WIZ ARID5B CASP8AP2 LCORL CHD8 NUP214 HUWE1 ECPAS ADNP PHC1 CRKL NCOR1 KMT2D USO1 ATF7IP DOCK7 LRP2 ANKRD17 | 3.08e-16 | 418 | 266 | 26 | 34709266 | |
| Pubmed | TET2 SP2 NR2C2 HIVEP1 ACACB TBL1Y PSMA2 PABPC4 TRRAP CIC EMSY PHF21A BPTF KMT2C JUP CPSF4 WIZ MYL6B ARID5B MITF NFYA SLC25A11 SAP130 NCOA2 HSPG2 ARID3A CALM1 EP400 CALM2 MAP3K8 CHD8 NUP214 ADNP MRPL2 NCOR1 ANGPTL6 KMT2D SMC3 ATF7IP SLC25A10 LRP2 ANKRD17 TP53BP1 | 1.58e-14 | 1429 | 266 | 43 | 35140242 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NR2C2 TBL1Y TRRAP CIC EMSY MEIS1 PHF21A BPTF WIZ A2ML1 NFYA SAP130 LRRC41 NCOA2 ZBTB2 ARID3A EP400 MAP3K8 FOSB BTAF1 HUWE1 REV3L CPS1 ECPAS ADNP PRPF8 NCOR1 KMT2D SMC3 USO1 ANKRD17 ALYREF TP53BP1 | 3.06e-14 | 857 | 266 | 33 | 25609649 |
| Pubmed | TBL1Y TBC1D5 DLGAP5 TENM2 EMSY SIRPG STOX2 WIZ PLPPR4 BAIAP2 GNB1 WNK3 CAP2 NCOA2 CALM1 NRCAM CALM2 PKP4 SPATA20 CHD8 HUWE1 SIK3 ADNP NCOR1 HOOK3 SEC24C ATF7IP PDE4DIP DOCK7 ANKRD17 ALYREF CTNNA1 PCBP1 TP53BP1 | 1.43e-13 | 963 | 266 | 34 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MED14 KDM3B MAST2 ZZEF1 PLXNB2 TRRAP CIC RYR1 KMT2C FZR1 PHLDB1 WIZ CHST15 PKD1 HSPG2 ARID3A EP400 SZT2 TIMM23B LAMA5 SPATA20 CHD8 BTAF1 NUP214 HUWE1 REV3L TESK1 RABL6 NCOR1 HEYL KMT2D ZNF341 SETD5 LRP4 TOP3A | 1.36e-12 | 1105 | 266 | 35 | 35748872 |
| Pubmed | NR2C2 CIC BPTF WIZ SAP130 NCOA2 ARID3A EP400 ADNP NCOR1 KMT2D SMC3 | 1.87e-12 | 83 | 266 | 12 | 28794006 | |
| Pubmed | TET2 NR2C2 HIVEP1 MED14 KDM3B BCL6 CIC EMSY PHF21A CPSF4 WIZ ARID5B SAP130 NCOA2 EP400 CHD8 NCOR1 KMT2D | 3.63e-12 | 268 | 266 | 18 | 33640491 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP2 NR2C2 TBC1D5 KDM3B ZNF207 DAXX EMSY PHF21A MITF TAB1 MED26 MPO NCOA2 ARID3A EP400 CHD8 CPS1 ADNP NCOR1 ZNF106 SLTM PCBP1 | 5.99e-12 | 444 | 266 | 22 | 34795231 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | TBL1Y TRRAP EMSY BPTF KMT2C WIZ SUPT6H ARID5B SAP130 ZBTB2 EP400 PHC1 NCOR1 SMC3 | 8.16e-12 | 146 | 266 | 14 | 23892456 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | DLGAP5 MEIS1 BPTF CPSF4 WIZ SLC25A11 BAIAP2 GNL3L ARID3A EP400 LCORL CHD8 CPS1 ADNP PHC1 NCOR1 SMC3 SLTM ALYREF PCBP1 CHTOP | 1.04e-11 | 411 | 266 | 21 | 35182466 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO5B PABPC4 EXOC3 PLXNB2 TRRAP F5 BPTF JUP CPSF4 PHLDB1 SUPT6H MYL6B GNB1 PHIP IPO7 EP400 BTAF1 NUP214 HUWE1 IDH3B ADNP PRPF8 CRKL HOOK3 SEC24C SMC3 DOCK7 SLTM ALYREF CTNNA1 PCBP1 CHTOP | 1.91e-11 | 1024 | 266 | 32 | 24711643 |
| Pubmed | TET2 EARS2 DLGAP5 KDM3B ZZEF1 PHF21A KMT2C STOX2 PLPPR4 TELO2 SUPT6H CASP8AP2 EP400 SZT2 LAMA5 CHD8 SIK3 ANKRD50 ECPAS ADNP LRP4 ANKRD17 IGSF1 | 2.71e-11 | 529 | 266 | 23 | 14621295 | |
| Pubmed | TET2 NR2C2 HIVEP1 PSMA2 PABPC4 MED14 KDM3B ZNF207 TRRAP CIC EMSY PHF21A BPTF KMT2C WIZ SAP130 MPO NCOA2 ARID3A IPO7 EP400 LCORL DOCK8 CHD8 ECPAS ADNP NCOR1 KMT2D SMC3 SBDS ALYREF CHTOP TP53BP1 | 2.83e-11 | 1103 | 266 | 33 | 34189442 | |
| Pubmed | HIVEP1 DAXX CIC KMT2C JUP KIAA1549L NFYA NKTR BAIAP2 CAP2 INTS6L CASP8AP2 CHD8 NUP214 SIK3 ZNF106 USF3 SMC3 ATF7IP ANKRD17 CTNNA1 HERPUD1 | 3.45e-11 | 486 | 266 | 22 | 20936779 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 NR2C2 HIVEP1 ACACB EMSY PHF21A BPTF KMT2C WIZ ARID5B MITF NCOA2 ARID3A EP400 CHD8 NUP214 NCOR1 KMT2D CTNNA1 | 3.86e-11 | 351 | 266 | 19 | 38297188 |
| Pubmed | HIVEP1 PABPC4 UBQLN4 KDM3B ZZEF1 JUP PKD1 GPNMB SAP130 CAP2 HSPG2 UBQLN2 STBD1 DOCK8 LAMA5 HUWE1 NCOR1 HEYL ZNF106 KMT2D ZNF341 ATF7IP PDE4DIP | 2.40e-10 | 591 | 266 | 23 | 15231748 | |
| Pubmed | MED14 KDM3B TRRAP EMSY BPTF KMT2C JUP WIZ SLC25A11 TAB1 SAP130 NCOA2 EP400 CHD8 HUWE1 ADNP CRKL NCOR1 KMT2D DOCK7 PCBP1 TP53BP1 | 3.47e-10 | 549 | 266 | 22 | 38280479 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP2 NR2C2 EME1 DLGAP5 UBQLN4 TRRAP CIC EMSY PHF21A BPTF KMT2C CPSF4 WIZ SUPT6H ARID5B MITF NKTR SAP130 CASP8AP2 CALM1 EP400 NUP214 ADNP PRPF8 NCOR1 ZNF106 KMT2D ZIC5 SLTM ALYREF PCBP1 NAIF1 CHTOP TOP3A | 4.23e-10 | 1294 | 266 | 34 | 30804502 |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | UBQLN4 MED14 TRRAP EMSY BPTF KMT2C WIZ MED26 ZBTB2 EP400 ADNP PHC1 KMT2D | 6.28e-10 | 167 | 266 | 13 | 20362541 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | KDM3B TRRAP KMT2C WIZ ARID5B NCOA2 CALM1 ECPAS ADNP PRPF8 NCOR1 KMT2D SMC3 PCBP1 | 1.92e-09 | 220 | 266 | 14 | 35785414 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NR2C2 HIVEP1 DLGAP5 KDM3B DAXX TRRAP CIC EMSY BPTF WIZ PHIP LRRC41 KRT10 GNL3L ARID3A IPO7 LCORL CHD8 BTAF1 ADNP PHC1 SMC3 | 2.29e-09 | 608 | 266 | 22 | 36089195 |
| Pubmed | EARS2 LPCAT4 TIMM23 MAST2 ZZEF1 TRRAP PHF21A BPTF VPS52 WIZ TELO2 SLC25A11 SAP130 PHIP LRRC41 ZBTB2 GNL3L EP400 PKP4 RALYL CHD8 SIK3 IDH3B REV3L EAF1 SETD5 LRP2 LRP4 ANKRD17 CHTOP | 2.92e-09 | 1116 | 266 | 30 | 31753913 | |
| Pubmed | SP2 HIVEP1 ZFP57 KDM3B ZNF207 CIC MEIS1 PHF21A BPTF CPSF4 WIZ ARID5B NFYA ZNF282 NCOA2 ARID3A LCORL FOSB AIRE PHC1 ZDHHC20 NCOR1 MTF1 ZIC5 SLTM | 4.26e-09 | 808 | 266 | 25 | 20412781 | |
| Pubmed | PABPC4 ZNF207 IQCD TRRAP BPTF KMT2C CPSF4 SUPT6H PHIP IPO7 EP400 CHD8 NUP214 HUWE1 KMT2D SLTM ALYREF CTNNA1 TP53BP1 | 4.84e-09 | 469 | 266 | 19 | 27634302 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | EARS2 MED14 KDM3B TRRAP EMSY BPTF WIZ SAP130 EP400 CHD8 BTAF1 ECPAS ADNP NCOR1 KMT2D TP53BP1 | 1.07e-08 | 341 | 266 | 16 | 32971831 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PSMA2 LRSAM1 DLGAP5 EXOC3 TRRAP JUP PHLDB1 A2ML1 SLC25A11 PHIP MPO KRT2 GNL3L IPO7 EP400 PKP4 CHD8 NUP214 HUWE1 IDH3B ADNP PRPF8 SEC24C WDR11 SMC3 SBDS SLTM ANKRD17 ALYREF PCBP1 CHTOP TP53BP1 | 1.76e-08 | 1353 | 266 | 32 | 29467282 |
| Pubmed | TET2 FGFR1OP2 RELN LRSAM1 UBQLN4 DCN WIZ PKD1 ARID5B BAIAP2 GNB1 CAP2 NCOA2 ZCCHC12 UBQLN2 CALM1 NRCAM EFEMP2 AIRE HUWE1 REV3L PRPF8 FEZ1 PDE4DIP WIF1 LRP2 LRP4 CERCAM CTNNA1 PCBP1 ECE2 | 1.92e-08 | 1285 | 266 | 31 | 35914814 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | NR2C2 MYO5B CIC JUP WIZ SLC25A11 SAP130 LRRC41 EP400 CHD8 HUWE1 ADNP PRPF8 SEC24C SMC3 ZIC5 SLC25A10 PCBP1 CHTOP TP53BP1 | 3.03e-08 | 583 | 266 | 20 | 29844126 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 LRSAM1 BAK1 EXOC3 DAXX ZCCHC2 CIC EMSY DDX11 SUPT6H ARID5B NCOA2 CASP8AP2 EP400 HUWE1 NCOR1 USO1 ATF7IP TOP3A TP53BP1 | 3.48e-08 | 588 | 266 | 20 | 38580884 |
| Pubmed | DENND4A TBC1D5 KDM3B EXOC3 MAST2 ZZEF1 SLC25A11 LRRC41 GNL3L PKP4 CHD8 BTAF1 SIK3 ANKRD50 CEMIP WDR11 SLC25A10 DOCK7 SLTM ANKRD17 TOP3A | 3.76e-08 | 650 | 266 | 21 | 38777146 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EME1 HIVEP1 DLGAP5 MED14 KDM3B DAXX TRRAP CIC EMSY BPTF EP400 BTAF1 NUP214 HUWE1 ECPAS NCOR1 ZNF106 KMT2D SEC24C ANKRD17 CTNNA1 PCBP1 TP53BP1 | 3.81e-08 | 774 | 266 | 23 | 15302935 |
| Pubmed | Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability. | SLC25A11 GNB1 KRT2 KRT10 CALM1 CALM2 CALM3 IDH3B ECPAS SLC25A10 PCBP1 | 4.84e-08 | 160 | 266 | 11 | 23798571 |
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 4.96e-08 | 6 | 266 | 4 | 2788608 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 4.96e-08 | 6 | 266 | 4 | 6608795 | |
| Pubmed | 4.96e-08 | 6 | 266 | 4 | 2452973 | ||
| Pubmed | 4.96e-08 | 6 | 266 | 4 | 15286789 | ||
| Pubmed | 4.96e-08 | 6 | 266 | 4 | 21299499 | ||
| Pubmed | 4.96e-08 | 6 | 266 | 4 | 2081604 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACB LRSAM1 EXOC3 TRRAP TGM5 KMT2C PHLDB1 GNL3L NUP214 ECPAS PRPF8 RABL6 ZNF106 SMC3 SLC25A10 CTNNA1 CDH7 CHTOP | 6.77e-08 | 497 | 266 | 18 | 36774506 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 SP2 NR2C2 HIVEP1 PHF21A KMT2C WIZ ARID5B NCOA2 IPO7 EP400 LCORL PCLO KMT2D ATF7IP MYO15A | 9.05e-08 | 398 | 266 | 16 | 35016035 |
| Pubmed | 9.22e-08 | 73 | 266 | 8 | 35973989 | ||
| Pubmed | HIVEP1 ELOA2 ACACB DLGAP5 KDM3B DCN CIC RYR1 PHLDB1 ARID5B LRRC41 NCOA2 IPO7 TNC SIK3 IDH3B REV3L NCOR1 KMT2D ANKRD17 | 1.30e-07 | 638 | 266 | 20 | 31182584 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | EME1 ACACB KDM3B JUP WIZ IPO7 EP400 CHD8 NUP214 ADNP CRKL NCOR1 SEC24C ATF7IP PCBP1 | 1.31e-07 | 357 | 266 | 15 | 37059091 |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | TIMM23 STOX2 PHLDB1 VPS52 PLPPR4 TAB1 GNB1 TIMM23B PCLO PKP4 HOOK3 MYO1F | 1.37e-07 | 218 | 266 | 12 | 33378226 |
| Pubmed | PABPC4 TRRAP BPTF SUPT6H PHIP COL5A1 IPO7 CHD8 NUP214 HUWE1 ECPAS ADNP PRPF8 SEC24C DOCK7 SLTM ANKRD17 ALYREF CTNNA1 TP53BP1 | 1.88e-07 | 653 | 266 | 20 | 22586326 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ACACB TBC1D5 ARFIP2 MAST2 EMSY VPS52 MYL6B ARHGAP29 SLC25A11 TAB1 BAIAP2 GNB1 PIH1D1 PKP4 SIK3 ECPAS CRKL KLHL22 NCOR1 HOOK3 WDR11 LRP2 PCBP1 | 2.15e-07 | 853 | 266 | 23 | 28718761 |
| Pubmed | 2.29e-07 | 8 | 266 | 4 | 12414807 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | PHF21A BPTF WIZ SUPT6H ARID5B SAP130 EP400 CHD8 ADNP TP53BP1 | 2.65e-07 | 150 | 266 | 10 | 28242625 |
| Pubmed | 3.38e-07 | 118 | 266 | 9 | 21078624 | ||
| Pubmed | 3.90e-07 | 120 | 266 | 9 | 27320910 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NR2C2 HIVEP1 PABPC4 DLGAP5 ZNF207 SSX2 CIC EMSY BPTF JUP WIZ SAP130 PHIP EP400 CHD8 NUP214 ADNP PRPF8 NCOR1 ATF7IP SLTM ALYREF PCBP1 TP53BP1 | 4.04e-07 | 954 | 266 | 24 | 36373674 |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 29932249 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 32697825 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 4.42e-07 | 3 | 266 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 4.42e-07 | 3 | 266 | 3 | 9923700 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 4.42e-07 | 3 | 266 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 4.42e-07 | 3 | 266 | 3 | 8573130 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 10899953 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 4.42e-07 | 3 | 266 | 3 | 21827821 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 8862395 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 15299664 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 22063648 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 14978283 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 33191766 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 19651602 | ||
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 4.42e-07 | 3 | 266 | 3 | 3384819 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 21799007 | ||
| Pubmed | SSX2-4 expression in early-stage non-small cell lung cancer. | 4.42e-07 | 3 | 266 | 3 | 24645645 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 4.42e-07 | 3 | 266 | 3 | 18786401 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 11072229 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 15063758 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 4.42e-07 | 3 | 266 | 3 | 17582331 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 18370588 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 4.42e-07 | 3 | 266 | 3 | 9278050 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 4.42e-07 | 3 | 266 | 3 | 11847276 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 10416864 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 7828884 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 4.42e-07 | 3 | 266 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 4.42e-07 | 3 | 266 | 3 | 15632291 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 4.42e-07 | 3 | 266 | 3 | 8631777 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 18553937 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 4.42e-07 | 3 | 266 | 3 | 11054265 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 18940602 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 25268113 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 26969752 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 4.42e-07 | 3 | 266 | 3 | 11807546 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 8312049 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 30982860 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 37380439 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 4.42e-07 | 3 | 266 | 3 | 11710561 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 4.42e-07 | 3 | 266 | 3 | 9362478 | |
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 4.42e-07 | 3 | 266 | 3 | 20956522 | |
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 12527308 | ||
| Pubmed | 4.42e-07 | 3 | 266 | 3 | 16229872 | ||
| Interaction | HNF4A interactions | NR2C2 HIVEP1 PABPC4 MED14 TRRAP CIC EMSY BPTF KMT2C WIZ SAP130 NCOA2 ARID3A EP400 ADNP NCOR1 KMT2D SMC3 ATF7IP | 4.05e-09 | 275 | 263 | 19 | int:HNF4A |
| Interaction | HNF1B interactions | TET2 HIVEP1 TRRAP CIC BPTF KMT2C WIZ ARID5B SAP130 NCOA2 ARID3A EP400 NCOR1 KMT2D ATF7IP PCBP1 | 4.27e-09 | 190 | 263 | 16 | int:HNF1B |
| Interaction | EGR2 interactions | TET2 NR2C2 HIVEP1 EMSY PHF21A KMT2C WIZ MITF NCOA2 ARID3A EP400 NCOR1 KMT2D PDE4DIP CTNNA1 | 7.54e-09 | 171 | 263 | 15 | int:EGR2 |
| Interaction | AR interactions | TET2 NR2C2 HIVEP1 MYO5B PSMA2 MED14 KDM3B DAXX BCL6 TRRAP CIC EMSY PHF21A KMT2C FZR1 JUP CPSF4 WIZ TELO2 ARID5B GNB1 SAP130 MTARC1 NCOA2 CALM1 EP400 CHD8 HUWE1 ECPAS ADNP PRPF8 TIPARP NCOR1 KMT2D SMC3 CTNNA1 PCBP1 | 8.43e-09 | 992 | 263 | 37 | int:AR |
| Interaction | KDM1A interactions | TET2 NR2C2 HIVEP1 ACACB UBQLN4 TRRAP CIC PHF21A JUP WIZ GABPB2 ARID5B ARHGAP29 BAIAP2 CASP8AP2 EP400 LCORL CHD8 NUP214 HUWE1 ECPAS ADNP PHC1 CRKL TIPARP NCOR1 KMT2D USO1 ATF7IP PDE4DIP DOCK7 LRP2 ANKRD17 TP53BP1 ECE2 | 2.39e-08 | 941 | 263 | 35 | int:KDM1A |
| Interaction | SOX2 interactions | TET2 SP2 NR2C2 HIVEP1 PABPC4 MAST2 CIC RYR1 TGM5 BPTF KMT2C FZR1 CPSF4 WIZ MYL6B A2ML1 ARID5B MITF SLC25A11 SAP130 SHISA6 NCOA2 ARID3A IPO7 EP400 PKP4 WDR27 CHD8 NUP214 ADNP PRPF8 BCDIN3D TIPARP KLHL22 MRPL2 NCOR1 KMT2D SMC3 SLC25A10 DOCK7 SLTM ANKRD17 ALYREF RGS17 CHTOP | 2.61e-08 | 1422 | 263 | 45 | int:SOX2 |
| Interaction | HDAC2 interactions | TET2 NR2C2 PABPC4 UBQLN4 DAXX BCL6 SSX2 CIC EMSY PHF21A PRKD3 BPTF FZR1 JUP WIZ ARID5B TAB1 SAP130 KRT2 HSPG2 KRT10 ZBTB2 EP400 FOSB AIRE HUWE1 CPS1 PHC1 TIPARP NCOR1 SMC3 ANKRD17 DDX53 | 3.45e-08 | 865 | 263 | 33 | int:HDAC2 |
| Interaction | CCDC8 interactions | MYO5B PABPC4 EXOC3 PLXNB2 F5 FZR1 JUP CPSF4 PHLDB1 MYL6B ARID5B GNB1 C11orf52 IPO7 CALM1 EP400 CALM2 CALM3 BTAF1 HUWE1 ADNP PRPF8 HOOK3 SMC3 DOCK7 CTNNA1 DNAJC5B CHTOP | 4.07e-08 | 656 | 263 | 28 | int:CCDC8 |
| Interaction | MYOD1 interactions | IGFN1 HIVEP1 TRRAP BPTF KMT2C WIZ SETD3 NCOA2 ARID3A CALM1 EP400 CALM3 HUWE1 NCOR1 KMT2D | 4.14e-08 | 194 | 263 | 15 | int:MYOD1 |
| Interaction | PML interactions | TET2 SP2 NR2C2 EME1 TBC1D5 KDM3B TIMM23 ZNF207 DAXX BCL6 EMSY PHF21A MITF TAB1 MED26 SAP130 PHIP MPO NCOA2 CASP8AP2 ARID3A CALM1 EP400 CALM2 CALM3 CHD8 TIPARP NCOR1 ZNF106 USO1 ATF7IP SLTM PCBP1 TP53BP1 | 6.33e-08 | 933 | 263 | 34 | int:PML |
| Interaction | EN1 interactions | HIVEP1 CIC MEIS1 KMT2C WIZ SAP130 ARID3A EP400 NCOR1 KMT2D SMC3 | 2.07e-07 | 110 | 263 | 11 | int:EN1 |
| Interaction | NFIX interactions | NR2C2 HIVEP1 TRRAP CIC EMSY BPTF KMT2C WIZ SAP130 ARID3A EP400 TIPARP NCOR1 KMT2D SMC3 | 3.23e-07 | 227 | 263 | 15 | int:NFIX |
| Interaction | CREBBP interactions | HIVEP1 KDM3B DAXX BCL6 TRRAP MEIS1 JUP CPSF4 SUPT6H MITF NFYA NCOA2 CASP8AP2 ZBTB2 ZCCHC12 FOSB AIRE HUWE1 TIPARP NCOR1 ZNF106 KMT2D MTF1 ATF7IP TP53BP1 | 3.44e-07 | 599 | 263 | 25 | int:CREBBP |
| Interaction | BUB3 interactions | NR2C2 EXOC3 ZNF207 TRRAP CIC KMT2C FZR1 PIH1D1 PHIP UBQLN2 HUWE1 PRPF8 TIPARP KMT2D TP53BP1 | 4.28e-07 | 232 | 263 | 15 | int:BUB3 |
| Interaction | FEV interactions | SP2 NR2C2 HIVEP1 CIC EMSY PHF21A KMT2C WIZ NCOA2 ARID3A EP400 NCOR1 KMT2D SMC3 | 4.80e-07 | 203 | 263 | 14 | int:FEV |
| Interaction | CACNA1A interactions | HIVEP1 BCL6 VPS52 TELO2 GNB1 CACNA1B HSPG2 CALM2 CALM3 EFEMP2 REV3L | 6.44e-07 | 123 | 263 | 11 | int:CACNA1A |
| Interaction | CAMK2G interactions | FGFR1OP2 HIVEP1 RYR1 PHF21A DDX11 ARHGAP29 CIBAR2 BAIAP2 SHISA6 CALM1 CALM2 CALM3 MAP3K8 SLC5A5 SBDS | 6.58e-07 | 240 | 263 | 15 | int:CAMK2G |
| Interaction | ERG interactions | TET2 HIVEP1 CIC EMSY KMT2C MITF NCOA2 ARID3A HUWE1 PRPF8 NCOR1 KMT2D ATF7IP PCBP1 | 1.48e-06 | 223 | 263 | 14 | int:ERG |
| Interaction | NANOG interactions | ACACB TRRAP EMSY BPTF KMT2C WIZ SUPT6H ARID5B SAP130 ZBTB2 GNL3L ARID3A EP400 HUWE1 ECPAS PHC1 KLHL22 NCOR1 SMC3 ALYREF TP53BP1 | 1.53e-06 | 481 | 263 | 21 | int:NANOG |
| Interaction | KLF3 interactions | NR2C2 HIVEP1 CIC EMSY PHF21A BPTF WIZ ARID5B SAP130 ARID3A EP400 NCOR1 KMT2D ATF7IP | 1.92e-06 | 228 | 263 | 14 | int:KLF3 |
| Interaction | EED interactions | NR2C2 ACACB MYO5B LAMA1 MED14 SSX2 PLXNB2 TRRAP BPTF JUP CPSF4 WIZ SUPT6H SLC25A11 SAP130 KRT2 HSPG2 KRT10 ZBTB2 IPO7 CALM1 EP400 SZT2 PKP4 LAMA5 NUP214 HUWE1 CUBN ADNP PRPF8 PHC1 NCOR1 SEC24C SMC3 USO1 SLC25A10 SLTM ALYREF CTNNA1 PCBP1 TP53BP1 | 2.04e-06 | 1445 | 263 | 41 | int:EED |
| Interaction | H3C3 interactions | NR2C2 HIVEP1 DLGAP5 KDM3B DAXX TRRAP CIC BPTF WIZ SUPT6H PHIP LRRC41 KRT10 GNL3L ARID3A IPO7 LCORL CHD8 ADNP PHC1 SMC3 | 2.41e-06 | 495 | 263 | 21 | int:H3C3 |
| Interaction | POU5F1 interactions | ACACB LAMA1 TRRAP EMSY BPTF MITF GNB1 SAP130 LRRC41 KRT2 HSPG2 KRT10 ZBTB2 EP400 HUWE1 IDH3B CUBN ECPAS PHC1 SMC3 ZIC5 ANKRD17 TP53BP1 | 2.76e-06 | 584 | 263 | 23 | int:POU5F1 |
| Interaction | HDAC1 interactions | TET2 NR2C2 HIVEP1 ACACB UBQLN4 DAXX BCL6 SSX2 CIC EMSY PHF21A BPTF FZR1 JUP WIZ ARID5B NFYA SAP130 CASP8AP2 ZBTB2 EP400 AIRE CHD8 NUP214 ECPAS ADNP CRKL TIPARP NCOR1 KMT2D SMC3 USO1 DOCK7 ANKRD17 | 3.21e-06 | 1108 | 263 | 34 | int:HDAC1 |
| Interaction | TEAD1 interactions | HIVEP1 TRRAP CIC BPTF KMT2C WIZ ARID5B ARID3A CALM1 NCOR1 KMT2D SMC3 | 3.59e-06 | 176 | 263 | 12 | int:TEAD1 |
| Interaction | FOS interactions | EPHB2 HIVEP1 ACACB CIC KMT2C WIZ MYL6B MITF NCOA2 ARID3A CALM1 EP400 FOSB NCOR1 KMT2D ANKRD17 | 3.75e-06 | 312 | 263 | 16 | int:FOS |
| Interaction | DYNLL1 interactions | NR2C2 UBQLN4 ZNF207 MAST2 KMT2C FZR1 JUP STOX2 PIH1D1 SAP130 ZBTB2 GNL3L UBQLN2 ADNP PRPF8 TIPARP PDE4DIP SLC25A10 DOCK7 PCBP1 TP53BP1 | 3.83e-06 | 510 | 263 | 21 | int:DYNLL1 |
| Interaction | ELF2 interactions | EPHB2 EPHB3 NR2C2 HIVEP1 TRRAP EMSY BPTF SAP130 CALM1 EP400 CTLA4 | 6.66e-06 | 156 | 263 | 11 | int:ELF2 |
| Interaction | SLX4 interactions | EME1 ACACB KDM3B DAXX EMSY JUP WIZ SUPT6H IPO7 EP400 CHD8 NUP214 REV3L ADNP CRKL NCOR1 ZNF106 SEC24C SMC3 ATF7IP PCBP1 TP53BP1 | 6.66e-06 | 572 | 263 | 22 | int:SLX4 |
| Interaction | KLF15 interactions | SP2 NR2C2 HIVEP1 PSMA2 CIC EMSY KMT2C SAP130 NCOA2 AMY1C ARID3A IPO7 EP400 NCOR1 KMT2D | 6.82e-06 | 290 | 263 | 15 | int:KLF15 |
| Interaction | TOP3B interactions | MED14 KDM3B MAST2 ZZEF1 PLXNB2 TRRAP CIC RYR1 KMT2C FZR1 PHLDB1 WIZ CHST15 PKD1 SLC25A11 HSPG2 ARID3A EP400 CALM2 SZT2 TIMM23B LAMA5 SPATA20 CHD8 BTAF1 NUP214 HUWE1 REV3L TESK1 CRKL RABL6 NCOR1 HEYL KMT2D ZNF341 SETD5 LRP4 ANKRD17 TOP3A TP53BP1 | 7.58e-06 | 1470 | 263 | 40 | int:TOP3B |
| Interaction | FBXO22 interactions | ACACB LRSAM1 EXOC3 TRRAP TGM5 KMT2C PHLDB1 PIH1D1 GNL3L NUP214 ECPAS PRPF8 RABL6 NCOR1 ZNF106 SMC3 SLC25A10 CTNNA1 CDH7 CHTOP TP53BP1 | 9.20e-06 | 540 | 263 | 21 | int:FBXO22 |
| Interaction | HNF1A interactions | 9.74e-06 | 80 | 263 | 8 | int:HNF1A | |
| Interaction | FOXL1 interactions | NR2C2 HIVEP1 CIC KMT2C ARID5B ARID3A CALM2 BTAF1 ECPAS NCOR1 KMT2D SMC3 | 1.08e-05 | 196 | 263 | 12 | int:FOXL1 |
| Interaction | SP7 interactions | TET2 HIVEP1 CIC KMT2C CPSF4 WIZ ARID5B MITF SLC25A11 SAP130 NCOA2 ARID3A EP400 NCOR1 KMT2D | 1.20e-05 | 304 | 263 | 15 | int:SP7 |
| Interaction | LGALS7 interactions | 1.47e-05 | 139 | 263 | 10 | int:LGALS7 | |
| Interaction | CEBPA interactions | TET2 NR2C2 HIVEP1 PSMA2 PABPC4 MED14 KDM3B ZNF207 TRRAP CIC EMSY PHF21A BPTF KMT2C WIZ NFYA SLC25A11 SAP130 MPO NCOA2 ARID3A IPO7 EP400 LCORL DOCK8 CHD8 ECPAS ADNP NCOR1 KMT2D SMC3 SBDS ALYREF CHTOP TP53BP1 | 1.52e-05 | 1245 | 263 | 35 | int:CEBPA |
| Interaction | TLX1 interactions | HIVEP1 CIC MEIS1 KMT2C WIZ SAP130 NCOA2 ARID3A NCOR1 KMT2D SMC3 | 1.97e-05 | 175 | 263 | 11 | int:TLX1 |
| Interaction | ELF4 interactions | 2.02e-05 | 115 | 263 | 9 | int:ELF4 | |
| Interaction | TBXT interactions | 2.16e-05 | 116 | 263 | 9 | int:TBXT | |
| Interaction | NUP43 interactions | NR2C2 EME1 HIVEP1 ACACB CCDC168 EMSY PHF21A BPTF SUPT6H LMLN NKTR BAIAP2 PHIP CASP8AP2 GNL3L EP400 SZT2 CHD8 NUP214 NCOR1 KMT2D ATF7IP | 2.62e-05 | 625 | 263 | 22 | int:NUP43 |
| Interaction | RNF2 interactions | PABPC4 MED14 SSX2 TRRAP CIC EMSY PHF21A WIZ MYL6B SLC25A11 PHIP IPO7 CALM1 EP400 PCLO HUWE1 ADNP PRPF8 PHC1 TIPARP KMT2D SMC3 SBDS PDE4DIP SLC25A10 ALYREF CHTOP | 2.71e-05 | 866 | 263 | 27 | int:RNF2 |
| Interaction | MAD2L1 interactions | NR2C2 HIVEP1 KDM3B DAXX CIC BPTF NCOA2 IPO7 CHD8 REV3L ADNP TIPARP ATF7IP | 2.89e-05 | 252 | 263 | 13 | int:MAD2L1 |
| Interaction | KLF8 interactions | NR2C2 HIVEP1 PSMA2 CIC EMSY PHF21A BPTF WIZ SAP130 NCOA2 EP400 ADNP KMT2D SMC3 ATF7IP | 3.01e-05 | 329 | 263 | 15 | int:KLF8 |
| Interaction | BSG interactions | EARS2 EXOC3 TRRAP VPS52 TELO2 SLC25A11 GNB1 C11orf52 ZBTB2 GNL3L UBQLN2 IPO7 CALM1 CALM2 CALM3 DOCK8 BTAF1 HUWE1 ECPAS PRPF8 SLC25A10 DNAJC5B | 3.02e-05 | 631 | 263 | 22 | int:BSG |
| Interaction | ETS1 interactions | 3.03e-05 | 121 | 263 | 9 | int:ETS1 | |
| Interaction | TLX3 interactions | TET2 DENND4A HIVEP1 CIC MEIS1 KMT2C WIZ NCOA2 ARID3A FOSB EFEMP2 NCOR1 KMT2D TP53BP1 | 3.09e-05 | 291 | 263 | 14 | int:TLX3 |
| Interaction | GATA4 interactions | DLGAP5 BPTF CPSF4 WIZ SLC25A11 EP400 CALM2 LCORL CHD8 CPS1 PHC1 NCOR1 SMC3 SLTM ALYREF PCBP1 CHTOP | 3.09e-05 | 411 | 263 | 17 | int:GATA4 |
| Interaction | TERF2IP interactions | HIVEP1 KDM3B CIC EMSY BPTF WIZ SUPT6H SAP130 NCOA2 ZBTB2 ARID3A EP400 CHD8 BTAF1 ADNP PHC1 NCOR1 SBDS ATF7IP NAIF1 | 4.11e-05 | 552 | 263 | 20 | int:TERF2IP |
| Interaction | TFCP2L1 interactions | 4.65e-05 | 99 | 263 | 8 | int:TFCP2L1 | |
| Interaction | PHF21A interactions | HIVEP1 ACACB CIC PHF21A ARID5B CASP8AP2 CHD8 NUP214 HUWE1 ECPAS CRKL TIPARP KMT2D USO1 DOCK7 | 4.85e-05 | 343 | 263 | 15 | int:PHF21A |
| Interaction | KLF12 interactions | NR2C2 HIVEP1 TRRAP CIC EMSY WIZ ARID3A EP400 MRPL2 SMC3 ATF7IP | 5.10e-05 | 194 | 263 | 11 | int:KLF12 |
| Interaction | NPHP1 interactions | 5.33e-05 | 130 | 263 | 9 | int:NPHP1 | |
| Interaction | KLF5 interactions | TET2 HIVEP1 PSMA2 CIC KMT2C JUP NCOA2 ARID3A EP400 NCOR1 KMT2D | 5.34e-05 | 195 | 263 | 11 | int:KLF5 |
| Interaction | CTNNB1 interactions | EPHB2 MYO5B PABPC4 BCL6 TRRAP FZR1 JUP PKD1 MITF NFYA SLC25A11 C11orf52 NCOA2 ZBTB2 CALM1 EP400 PKP4 USP29 CHD8 NUP214 HUWE1 IDH3B ADNP KMT2D SEC24C USO1 CTNNA1 PCBP1 CDH7 | 5.89e-05 | 1009 | 263 | 29 | int:CTNNB1 |
| Interaction | DDX39B interactions | NR2C2 PABPC4 FZR1 JUP A2ML1 TAB1 BAIAP2 GNB1 KRT2 KRT10 ZBTB2 IPO7 CALM1 HUWE1 PRPF8 TIPARP ALYREF PCBP1 CHTOP TP53BP1 | 6.41e-05 | 570 | 263 | 20 | int:DDX39B |
| Interaction | LHX4 interactions | 6.74e-05 | 166 | 263 | 10 | int:LHX4 | |
| Interaction | SPATA17 interactions | 7.40e-05 | 7 | 263 | 3 | int:SPATA17 | |
| Interaction | HIF1A interactions | EARS2 MED14 SSX4 TRRAP FZR1 JUP TELO2 MITF NCOA2 EP400 USP29 BTAF1 IDH3B ECPAS PRPF8 MTF1 PCBP1 | 7.40e-05 | 441 | 263 | 17 | int:HIF1A |
| Interaction | CIC interactions | NR2C2 MYO5B CIC PHF21A JUP WIZ SLC25A11 SAP130 LRRC41 EP400 CHD8 HUWE1 ADNP PRPF8 TIPARP SEC24C SMC3 ZIC5 SLC25A10 PCBP1 CHTOP TP53BP1 | 7.84e-05 | 673 | 263 | 22 | int:CIC |
| Interaction | KCNA3 interactions | PABPC4 LAMA1 EXOC3 RYR1 KMT2C JUP ARHGAP29 SLC25A11 NCOA2 CACNA1B STBD1 IPO7 SZT2 NUP214 ANKRD50 ECPAS CRKL RABL6 SEC24C SMC3 USO1 DOCK7 LRP2 ANKRD17 CTNNA1 PCBP1 | 7.87e-05 | 871 | 263 | 26 | int:KCNA3 |
| Interaction | TAF10 interactions | 8.09e-05 | 107 | 263 | 8 | int:TAF10 | |
| Interaction | MEN1 interactions | EARS2 PABPC4 MED14 KDM3B DAXX TRRAP EMSY BPTF KMT2C WIZ SLC25A11 SAP130 COL5A1 GNL3L EP400 LAMA5 CHD8 BTAF1 ECPAS ADNP PRPF8 NCOR1 KMT2D SMC3 SLC25A10 SLTM ANKRD17 CHTOP TP53BP1 | 8.31e-05 | 1029 | 263 | 29 | int:MEN1 |
| Interaction | CDH15 interactions | 9.42e-05 | 19 | 263 | 4 | int:CDH15 | |
| Interaction | SOX7 interactions | 9.83e-05 | 82 | 263 | 7 | int:SOX7 | |
| Interaction | PAX6 interactions | NR2C2 HIVEP1 CIC PHF21A BPTF KMT2C WIZ MITF SAP130 ARID3A EP400 NCOR1 KMT2D EAF1 SMC3 | 1.00e-04 | 366 | 263 | 15 | int:PAX6 |
| Interaction | KPNB1 interactions | NR2C2 DLGAP5 ZNF207 CIC PRKD3 FZR1 NFYA PIH1D1 ZBTB2 UBQLN2 IPO7 AIRE CHD8 NUP214 HUWE1 PRPF8 TIPARP SMC3 TP53BP1 | 1.04e-04 | 544 | 263 | 19 | int:KPNB1 |
| Interaction | PAX8 interactions | 1.05e-04 | 111 | 263 | 8 | int:PAX8 | |
| Interaction | KPNA3 interactions | MED14 CIC BPTF FZR1 ARHGAP29 ZCCHC12 CHD8 NUP214 HUWE1 TIPARP PCBP1 TP53BP1 | 1.08e-04 | 248 | 263 | 12 | int:KPNA3 |
| Interaction | PARP1 interactions | NR2C2 HIVEP1 MYO5B MED14 DAXX TRRAP CIC BPTF FZR1 JUP WIZ SUPT6H NFYA PIH1D1 PHIP ARID3A EP400 AIRE BTAF1 HUWE1 PRPF8 PHC1 TIPARP RABL6 ZNF106 SEC24C USO1 MTF1 DOCK7 CTNNA1 PCBP1 CHTOP TOP3A TP53BP1 | 1.09e-04 | 1316 | 263 | 34 | int:PARP1 |
| Interaction | KCNN1 interactions | 1.17e-04 | 8 | 263 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 1.17e-04 | 8 | 263 | 3 | int:ARPP21 | |
| Interaction | ICE1 interactions | 1.18e-04 | 59 | 263 | 6 | int:ICE1 | |
| Interaction | FARSA interactions | NR2C2 ARHGAP36 BCL6 CIC FZR1 ARHGAP29 PIH1D1 HUWE1 ECPAS TIPARP | 1.20e-04 | 178 | 263 | 10 | int:FARSA |
| Interaction | CDKN1A interactions | TRRAP FZR1 WIZ HPD SUPT6H MITF NFYA SLC25A11 SHISA6 PRPF8 NCOR1 PDE4DIP DOCK7 ANKRD17 TP53BP1 | 1.31e-04 | 375 | 263 | 15 | int:CDKN1A |
| Interaction | LHX2 interactions | 1.51e-04 | 183 | 263 | 10 | int:LHX2 | |
| Interaction | TCAF1 interactions | 1.51e-04 | 117 | 263 | 8 | int:TCAF1 | |
| Interaction | ARHGEF12 interactions | 1.51e-04 | 117 | 263 | 8 | int:ARHGEF12 | |
| Interaction | TNIK interactions | EPHB2 FGFR1OP2 WIZ BAIAP2 CAP2 C11orf52 CHD8 HUWE1 ANKRD50 ADNP SEC24C PDE4DIP DOCK7 CTNNA1 TP53BP1 | 1.56e-04 | 381 | 263 | 15 | int:TNIK |
| Interaction | ADRB2 interactions | MITF SLC25A11 GNB1 KRT2 KRT10 GNL3L CALM1 CALM2 CALM3 IDH3B ECPAS SLC25A10 RGS17 PCBP1 | 1.58e-04 | 339 | 263 | 14 | int:ADRB2 |
| Interaction | MORF4L1 interactions | AP5S1 TRRAP EMSY FZR1 TAB1 ARID3A CALM1 EP400 USO1 CHTOP TP53BP1 | 1.63e-04 | 221 | 263 | 11 | int:MORF4L1 |
| Interaction | EPHA4 interactions | 1.88e-04 | 188 | 263 | 10 | int:EPHA4 | |
| Interaction | BAG2 interactions | NR2C2 DLGAP5 KDM3B CIC BPTF FZR1 WIZ SUPT6H TAB1 WNK3 NCOA2 HUWE1 ADNP PRPF8 PHC1 TIPARP SLC5A5 NCOR1 DOCK7 DNAJC5B | 2.07e-04 | 622 | 263 | 20 | int:BAG2 |
| Interaction | DMAP1 interactions | 2.14e-04 | 191 | 263 | 10 | int:DMAP1 | |
| Interaction | PAX7 interactions | 2.26e-04 | 124 | 263 | 8 | int:PAX7 | |
| Interaction | AMY2B interactions | 2.46e-04 | 10 | 263 | 3 | int:AMY2B | |
| Interaction | SCRT2 interactions | 2.46e-04 | 10 | 263 | 3 | int:SCRT2 | |
| Interaction | IQCG interactions | 2.46e-04 | 10 | 263 | 3 | int:IQCG | |
| Interaction | SOX17 interactions | 2.47e-04 | 95 | 263 | 7 | int:SOX17 | |
| Interaction | GCM1 interactions | 2.59e-04 | 68 | 263 | 6 | int:GCM1 | |
| Interaction | ZBTB25 interactions | 2.61e-04 | 44 | 263 | 5 | int:ZBTB25 | |
| Interaction | PELO interactions | 2.72e-04 | 161 | 263 | 9 | int:PELO | |
| Interaction | RCOR1 interactions | HIVEP1 ACACB CIC PHF21A ARID5B PHIP CASP8AP2 CHD8 HUWE1 ECPAS CRKL NCOR1 KMT2D DOCK7 ANKRD17 TP53BP1 ECE2 | 2.85e-04 | 494 | 263 | 17 | int:RCOR1 |
| Interaction | SMC5 interactions | NR2C2 HIVEP1 PABPC4 DLGAP5 ZNF207 SSX2 CIC EMSY BPTF JUP WIZ SAP130 PHIP EP400 CHD8 NUP214 REV3L ADNP PRPF8 TIPARP NCOR1 SMC3 ATF7IP SLTM ALYREF PCBP1 TP53BP1 | 2.93e-04 | 1000 | 263 | 27 | int:SMC5 |
| Interaction | GATA2 interactions | 2.98e-04 | 199 | 263 | 10 | int:GATA2 | |
| Interaction | H2AX interactions | NR2C2 PAIP2B PHF21A BPTF FZR1 WIZ SUPT6H MYL6B SAP130 RAD17 CALM1 CALM2 CHD8 HUWE1 CPS1 ADNP SMC3 ALYREF TP53BP1 | 3.11e-04 | 593 | 263 | 19 | int:H2AX |
| Interaction | PAX9 interactions | 3.12e-04 | 130 | 263 | 8 | int:PAX9 | |
| Interaction | SUZ12 interactions | TBL1Y PABPC4 ZNF207 IQCD SSX2 TRRAP BPTF SLC25A11 ZBTB2 EP400 CHD8 NUP214 PRPF8 TIPARP KMT2D SMC3 SLTM ALYREF CTNNA1 CHTOP | 3.24e-04 | 644 | 263 | 20 | int:SUZ12 |
| Interaction | SUPT5H interactions | HIVEP1 MED14 CIC SUPT6H CAP2 INTS6L EP400 PRPF8 NCOR1 ZNF106 KMT2D SEC24C SMC3 SETD5 WIF1 | 3.25e-04 | 408 | 263 | 15 | int:SUPT5H |
| Interaction | MKRN1 interactions | 3.27e-04 | 165 | 263 | 9 | int:MKRN1 | |
| Cytoband | 1p21 | 1.07e-05 | 24 | 266 | 4 | 1p21 | |
| Cytoband | Xp11.22 | 2.77e-04 | 54 | 266 | 4 | Xp11.22 | |
| Cytoband | 10q22-q23 | 3.31e-04 | 5 | 266 | 2 | 10q22-q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 3.90e-04 | 377 | 266 | 9 | chrXp11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 4.13e-04 | 107 | 266 | 5 | chr1p21 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 HIVEP1 DLGAP5 KDM3B MAST2 ZZEF1 TRRAP PHF21A BPTF DLC1 ARID5B MITF ARHGAP29 SETD3 PHIP CAP2 NCOA2 IPO7 PKP4 BTAF1 SIK3 REV3L ADNP TIPARP CEMIP SMC3 ANKRD17 TP53BP1 | 5.96e-08 | 856 | 266 | 28 | M4500 |
| Coexpression | NGUYEN_NOTCH1_TARGETS_DN | 2.07e-06 | 83 | 266 | 8 | M14650 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.65e-05 | 180 | 266 | 10 | M8239 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP | UBQLN4 TELO2 ARHGAP29 PHIP DNAH3 CALM2 TNC CHD8 HMCN1 ATF7IP | 1.99e-05 | 184 | 266 | 10 | M9988 |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 2.58e-05 | 85 | 266 | 7 | M41085 | |
| Coexpression | NABA_CORE_MATRISOME | RELN LAMA1 DCN INTS6L COL5A1 HSPG2 TNC EFEMP2 LAMA5 COL5A3 EYS HMCN1 | 2.70e-05 | 275 | 266 | 12 | M5884 |
| Coexpression | RUIZ_TNC_TARGETS_UP | 3.25e-05 | 156 | 266 | 9 | M988 | |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP | PAIP2B EXOC3 DCN PIK3IP1 DPEP2 NKTR COL5A1 EFEMP2 LAMA5 SIK3 | 3.42e-05 | 196 | 266 | 10 | M4532 |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN | 4.06e-05 | 200 | 266 | 10 | M3747 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 6.31e-05 | 132 | 266 | 8 | MM470 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | EXOC3 MAST2 BAIAP2 PHIP RAD17 AMY1A AMY1B AMY1C AMY2B UBQLN2 CALM1 PKP4 BTAF1 TP53BP1 | 6.43e-05 | 399 | 266 | 14 | M41172 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.70e-07 | 200 | 266 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 8.04e-07 | 168 | 266 | 9 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.56e-06 | 182 | 266 | 9 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 184 | 266 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 184 | 266 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 184 | 266 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-06 | 189 | 266 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-06 | 142 | 266 | 8 | ae495c8dd733f0fde66bddc281606543f21c0d4b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.88e-06 | 196 | 266 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.88e-06 | 196 | 266 | 9 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.00e-06 | 197 | 266 | 9 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-06 | 198 | 266 | 9 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 198 | 266 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 198 | 266 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.39e-06 | 200 | 266 | 9 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.39e-06 | 200 | 266 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.39e-06 | 200 | 266 | 9 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.39e-06 | 200 | 266 | 9 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.00e-06 | 171 | 266 | 8 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-06 | 172 | 266 | 8 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 178 | 266 | 8 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 178 | 266 | 8 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 179 | 266 | 8 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-05 | 180 | 266 | 8 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-05 | 180 | 266 | 8 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-05 | 182 | 266 | 8 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-05 | 182 | 266 | 8 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-05 | 183 | 266 | 8 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-05 | 183 | 266 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-05 | 183 | 266 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-05 | 183 | 266 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-05 | 184 | 266 | 8 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 186 | 266 | 8 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.72e-05 | 187 | 266 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-05 | 187 | 266 | 8 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-05 | 136 | 266 | 7 | a43b3db1754c619d328a26a2ba6af4756629a723 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.79e-05 | 188 | 266 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-05 | 188 | 266 | 8 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-05 | 191 | 266 | 8 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.00e-05 | 191 | 266 | 8 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.00e-05 | 191 | 266 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.08e-05 | 192 | 266 | 8 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue | 2.08e-05 | 192 | 266 | 8 | 04bd6e135733570e877af9460f87379ed0a5c5f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 195 | 266 | 8 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-05 | 196 | 266 | 8 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | mLN-T_cell-Treg|T_cell / Region, Cell class and subclass | 2.50e-05 | 197 | 266 | 8 | 3779489d57ebda33277c79cba037f4c73128c8ba | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 2.50e-05 | 197 | 266 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.50e-05 | 197 | 266 | 8 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.50e-05 | 197 | 266 | 8 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-05 | 197 | 266 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 197 | 266 | 8 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 197 | 266 | 8 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | (1)_T_cell-(15)_Treg|(1)_T_cell / shred on Cell_type and subtype | 2.50e-05 | 197 | 266 | 8 | 6e7723e8b977be35c60cc11ac7cfa4f71339441e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 2.50e-05 | 197 | 266 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 2.50e-05 | 197 | 266 | 8 | 3ad72b70406e8a4c6996ec41809b174a423dad38 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class | 2.50e-05 | 197 | 266 | 8 | 344801997b89bd81d8d5c3c872934de523233a8d | |
| ToppCell | mLN-(1)_T_cell-(15)_Treg|mLN / shred on region, Cell_type, and subtype | 2.59e-05 | 198 | 266 | 8 | d4885f9c59b275e4e50dfcfb51c5351bebba1769 | |
| ToppCell | mLN-T_cell-Treg|mLN / Region, Cell class and subclass | 2.59e-05 | 198 | 266 | 8 | 6ce9681d1287632956176239f223e71abb8de44f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 198 | 266 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.69e-05 | 199 | 266 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.69e-05 | 199 | 266 | 8 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.69e-05 | 199 | 266 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-05 | 199 | 266 | 8 | 2b567b6fd8addf059bbf2b72c55a7647aefdc595 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.69e-05 | 199 | 266 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.69e-05 | 199 | 266 | 8 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.69e-05 | 199 | 266 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.79e-05 | 200 | 266 | 8 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.79e-05 | 200 | 266 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.79e-05 | 200 | 266 | 8 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.79e-05 | 200 | 266 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.79e-05 | 200 | 266 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.79e-05 | 200 | 266 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.79e-05 | 200 | 266 | 8 | 09fd3cb31bcc02444f1045f01fe39bce09359d35 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.79e-05 | 200 | 266 | 8 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.79e-05 | 200 | 266 | 8 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.49e-05 | 151 | 266 | 7 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-05 | 160 | 266 | 7 | 5c931e859acf67c1c8664941e0e44d195f8ba75b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.04e-05 | 160 | 266 | 7 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.24e-05 | 161 | 266 | 7 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 162 | 266 | 7 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 162 | 266 | 7 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 162 | 266 | 7 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.67e-05 | 163 | 266 | 7 | ce07bc424ef99c547588b07f5c8b39ff0773ca9b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-05 | 165 | 266 | 7 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-05 | 165 | 266 | 7 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 167 | 266 | 7 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 167 | 266 | 7 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.63e-05 | 115 | 266 | 6 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.12e-05 | 169 | 266 | 7 | 481e611b5fface58f1630f206c0b04fb54e24011 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-05 | 171 | 266 | 7 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-05 | 171 | 266 | 7 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.95e-05 | 172 | 266 | 7 | c74c1d47b133eb5d0f762a06e421252a76b4672b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-3_PAX6_NABP1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.25e-05 | 173 | 266 | 7 | 0d38206e25434386b1aec2078067efc67b496c10 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 174 | 266 | 7 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.86e-05 | 175 | 266 | 7 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 176 | 266 | 7 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 176 | 266 | 7 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.85e-05 | 178 | 266 | 7 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.85e-05 | 178 | 266 | 7 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 9.85e-05 | 178 | 266 | 7 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| Computational | Neighborhood of DDB1 | DENND4A GPAA1 KDM3B DAXX TRRAP DDX11 CPSF4 SLC25A11 CALM2 HUWE1 IDH3B PRPF8 ANKRD17 TP53BP1 | 5.44e-05 | 246 | 177 | 14 | MORF_DDB1 |
| Computational | Neighborhood of CRKL | 8.21e-05 | 64 | 177 | 7 | GCM_CRKL | |
| Computational | Genes in the cancer module 97. | 2.06e-04 | 98 | 177 | 8 | MODULE_97 | |
| Computational | Genes in the cancer module 182. | 2.37e-04 | 100 | 177 | 8 | MODULE_182 | |
| Drug | AC1LAC07 | 4.76e-08 | 10 | 263 | 5 | CID000485275 | |
| Drug | R 623 | 2.56e-07 | 6 | 263 | 4 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 2.56e-07 | 6 | 263 | 4 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 2.56e-07 | 6 | 263 | 4 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 2.56e-07 | 6 | 263 | 4 | CID000127364 | |
| Drug | AC1LCMSV | 2.56e-07 | 6 | 263 | 4 | CID000633347 | |
| Drug | CNP-G3 | 2.56e-07 | 6 | 263 | 4 | CID003082910 | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; HL60; HT_HG-U133A | HIVEP1 BCL6 PIK3IP1 SUPT6H ARID5B BAIAP2 FOSB PCLO SIK3 TIPARP ATF7IP ZNF79 | 4.55e-07 | 163 | 263 | 12 | 2145_UP |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; MCF7; HT_HG-U133A | PAIP2B DCN ZZEF1 RYR1 FZR1 PHLDB1 WIZ MITF HSPG2 CRKL KLHL22 CTLA4 TOP3A | 5.62e-07 | 198 | 263 | 13 | 7224_UP |
| Drug | AC1L1I1P | 5.62e-07 | 62 | 263 | 8 | CID000004385 | |
| Drug | AC1L5BOU | 5.93e-07 | 7 | 263 | 4 | CID000174858 | |
| Drug | BG5P | 5.93e-07 | 7 | 263 | 4 | CID003082752 | |
| Drug | 2,6-ANS | 1.17e-06 | 8 | 263 | 4 | CID002762570 | |
| Drug | desethylaprophen | 1.17e-06 | 8 | 263 | 4 | CID000163919 | |
| Drug | azintamide | 1.17e-06 | 8 | 263 | 4 | CID000071105 | |
| Drug | NSC366363 | 1.52e-06 | 3 | 263 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 1.52e-06 | 3 | 263 | 3 | CID004630710 | |
| Drug | tatsiensine | 1.52e-06 | 3 | 263 | 3 | CID000163526 | |
| Drug | AC1N3UXZ | 1.52e-06 | 3 | 263 | 3 | CID004118625 | |
| Drug | delcosine | 1.52e-06 | 3 | 263 | 3 | CID000120726 | |
| Drug | alpha-maltosyl fluoride | 2.10e-06 | 9 | 263 | 4 | CID000194237 | |
| Drug | trestatin A | 2.10e-06 | 9 | 263 | 4 | CID003054994 | |
| Drug | H 187 | 2.10e-06 | 9 | 263 | 4 | CID000001742 | |
| Drug | Glc)4 | 3.46e-06 | 10 | 263 | 4 | CID000189098 | |
| Drug | Ro 20-0083 | 3.46e-06 | 10 | 263 | 4 | CID003082332 | |
| Drug | AC1L3M0Q | 3.46e-06 | 10 | 263 | 4 | CID000118008 | |
| Drug | loperamide | 3.65e-06 | 105 | 263 | 9 | CID000003954 | |
| Drug | BCDs | 3.86e-06 | 37 | 263 | 6 | CID000364214 | |
| Drug | validamycin D | 5.39e-06 | 11 | 263 | 4 | CID000166726 | |
| Drug | 1-(5-aminopentyl)-3-phenylthiourea | 5.39e-06 | 11 | 263 | 4 | CID003035524 | |
| Drug | FG5P | 5.39e-06 | 11 | 263 | 4 | CID000127486 | |
| Drug | CNP-G5 | 5.39e-06 | 11 | 263 | 4 | CID000127309 | |
| Drug | HgI2 | 5.39e-06 | 11 | 263 | 4 | CID000024485 | |
| Drug | 2C KM | 5.39e-06 | 11 | 263 | 4 | CID009549196 | |
| Drug | Nsc642900 | 6.04e-06 | 4 | 263 | 3 | CID000498959 | |
| Drug | N-PMT | 6.04e-06 | 4 | 263 | 3 | CID000194224 | |
| Drug | CTK0F9956 | 6.04e-06 | 4 | 263 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 6.04e-06 | 4 | 263 | 3 | CID006439702 | |
| Drug | cloxacepride | 6.04e-06 | 4 | 263 | 3 | CID000068859 | |
| Drug | chloraniformethan | 6.04e-06 | 4 | 263 | 3 | CID000030331 | |
| Drug | AC1MQT4V | 6.04e-06 | 4 | 263 | 3 | CID003482066 | |
| Drug | SAIB-SG | 6.04e-06 | 4 | 263 | 3 | CID002735139 | |
| Drug | Ti 233 | 6.04e-06 | 4 | 263 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 6.04e-06 | 4 | 263 | 3 | CID000080867 | |
| Drug | herbarumin III | 6.04e-06 | 4 | 263 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 6.04e-06 | 4 | 263 | 3 | CID000070583 | |
| Drug | KS-504e | 6.04e-06 | 4 | 263 | 3 | CID000129559 | |
| Drug | KS-504d | 6.04e-06 | 4 | 263 | 3 | CID000129557 | |
| Drug | Archanagelicine | 6.04e-06 | 4 | 263 | 3 | CID003083773 | |
| Drug | 2-nitropropyl acetate | 6.04e-06 | 4 | 263 | 3 | CID013573844 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 6.04e-06 | 4 | 263 | 3 | CID000127194 | |
| Drug | Dembrexine | 6.04e-06 | 4 | 263 | 3 | CID000072009 | |
| Drug | Roylin | 6.04e-06 | 4 | 263 | 3 | CID000099924 | |
| Drug | g lw | 6.04e-06 | 4 | 263 | 3 | CID000444139 | |
| Drug | KS-502 | 6.04e-06 | 4 | 263 | 3 | CID000129242 | |
| Drug | KS-501 | 6.04e-06 | 4 | 263 | 3 | CID000129240 | |
| Drug | beta-santalene | 6.04e-06 | 4 | 263 | 3 | CID000010534 | |
| Drug | 2'-methoxykobusin | 6.04e-06 | 4 | 263 | 3 | CID000637889 | |
| Drug | PS-990 | 6.04e-06 | 4 | 263 | 3 | CID000157810 | |
| Drug | azaprophen | 8.01e-06 | 12 | 263 | 4 | CID000129486 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ZCCHC2 PHF21A CHST15 ARID5B NFYA NCOA2 BTAF1 ARMCX5 REV3L ADNP SETD5 | 9.30e-06 | 182 | 263 | 11 | 3887_DN |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | BCL6 PIK3IP1 MITF ARHGAP29 COL5A1 PCLO CNNM4 FEZ1 MTF1 PDE4DIP ZNF79 | 1.09e-05 | 185 | 263 | 11 | 6945_UP |
| Drug | NSC708927 | 1.15e-05 | 13 | 263 | 4 | CID011970115 | |
| Drug | methyl 1'-epiacarviosin | 1.15e-05 | 13 | 263 | 4 | CID000197426 | |
| Drug | isoacarbose | 1.15e-05 | 13 | 263 | 4 | CID000449165 | |
| Drug | maltal | 1.15e-05 | 13 | 263 | 4 | CID000169427 | |
| Drug | APP 201-533 | 1.15e-05 | 13 | 263 | 4 | CID000133461 | |
| Drug | gallopamil | 1.22e-05 | 67 | 263 | 7 | CID000001234 | |
| Drug | tBuBHQ | 1.48e-05 | 69 | 263 | 7 | CID000002374 | |
| Drug | jujubogenin | 1.50e-05 | 5 | 263 | 3 | CID005318721 | |
| Drug | D 890 | 1.50e-05 | 5 | 263 | 3 | CID000134083 | |
| Drug | Deposiston | 1.50e-05 | 5 | 263 | 3 | CID003080829 | |
| Drug | NSC-36360 | 1.50e-05 | 5 | 263 | 3 | CID000133340 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.50e-05 | 5 | 263 | 3 | CID010358258 | |
| Drug | alpha-CAO | 1.50e-05 | 5 | 263 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 1.50e-05 | 5 | 263 | 3 | CID005356151 | |
| Drug | lunularic acid | 1.50e-05 | 5 | 263 | 3 | CID000161413 | |
| Drug | himachalene | 1.50e-05 | 5 | 263 | 3 | CID000015095 | |
| Drug | actinidine | 1.50e-05 | 5 | 263 | 3 | CID000068231 | |
| Drug | 4H-1,4-benzothiazin-3-one | 1.50e-05 | 5 | 263 | 3 | CID000021396 | |
| Drug | Y-acid | 1.50e-05 | 5 | 263 | 3 | CID000007022 | |
| Drug | C16AA | 1.50e-05 | 5 | 263 | 3 | CID000488017 | |
| Drug | auranthine | 1.50e-05 | 5 | 263 | 3 | CID000130919 | |
| Drug | 2TAA | 1.50e-05 | 5 | 263 | 3 | CID000127374 | |
| Drug | cimicifugic acid A | 1.50e-05 | 5 | 263 | 3 | CID006449879 | |
| Drug | silver perchlorate | 1.50e-05 | 5 | 263 | 3 | CID000024562 | |
| Drug | Ant-ATP | 1.50e-05 | 5 | 263 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 1.50e-05 | 5 | 263 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 1.50e-05 | 5 | 263 | 3 | CID005748474 | |
| Drug | Ac-dvda | 1.50e-05 | 5 | 263 | 3 | CID000146768 | |
| Drug | VUF 4576 | 1.50e-05 | 5 | 263 | 3 | CID000132784 | |
| Drug | AC1L4DZ4 | 1.50e-05 | 5 | 263 | 3 | CID000155287 | |
| Drug | Cyclodextrins | 1.59e-05 | 14 | 263 | 4 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 1.59e-05 | 14 | 263 | 4 | CID000012074 | |
| Drug | terephthaloyl chloride | 1.59e-05 | 14 | 263 | 4 | CID000007488 | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | EPHB2 TBC1D5 F5 NFYA COL5A1 ARID3A AIRE CRKL KMT2D CLCA2 LRP4 | 1.62e-05 | 193 | 263 | 11 | 6730_UP |
| Drug | pimozide | 1.73e-05 | 127 | 263 | 9 | CID000016362 | |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; HL60; HT_HG-U133A | GPR135 BCL6 DCN FZR1 DLC1 WIZ GNL3L HUWE1 HEYL PDE4DIP MYO15A | 1.86e-05 | 196 | 263 | 11 | 2447_UP |
| Drug | pp J | 1.87e-05 | 29 | 263 | 5 | CID006323476 | |
| Drug | clofibrate; Down 200; 100uM; MCF7; HG-U133A | EPHB2 BCL6 MEIS1 MTARC1 NCOA2 DNAH3 NUP214 HUWE1 CPS1 MTF1 HERPUD1 | 1.96e-05 | 197 | 263 | 11 | 444_DN |
| Disease | stimulant use measurement | 3.80e-06 | 28 | 254 | 5 | EFO_0600076 | |
| Disease | apolipoprotein A 1 measurement | TET2 ACACB MYO5B PABPC4 MEIS1 FZR1 DLC1 DPEP2 PHIP MTARC1 TRIM48 NCOA2 SIK3 CPS1 ZNF285 HEYL WDR11 EEPD1 DOCK7 RGS17 HERPUD1 TP53BP1 | 4.93e-06 | 848 | 254 | 22 | EFO_0004614 |
| Disease | triglyceride measurement, phospholipid measurement | 5.22e-06 | 146 | 254 | 9 | EFO_0004530, EFO_0004639 | |
| Disease | Malignant neoplasm of prostate | EPHB2 TET2 SSX2 KMT2C JUP VPS52 UCP3 MPO NCOA2 COL5A1 EFEMP2 COL5A3 SLC5A5 NCOR1 KMT2D USO1 LRP2 HERPUD1 | 7.57e-06 | 616 | 254 | 18 | C0376358 |
| Disease | Intellectual Disability | LAMA1 KDM3B TRRAP CIC PHF21A BPTF KMT2C GNB1 PHIP CACNA1B DOCK8 CHD8 RABL6 MTF1 LRP2 | 8.85e-06 | 447 | 254 | 15 | C3714756 |
| Disease | prostate cancer (is_marker_for) | 8.94e-06 | 156 | 254 | 9 | DOID:10283 (is_marker_for) | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 1.21e-05 | 162 | 254 | 9 | EFO_0004612, EFO_0007878 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 1.62e-05 | 168 | 254 | 9 | EFO_0004329, EFO_0004612 | |
| Disease | Malignant neoplasm of breast | MED14 CIC EMSY MEIS1 ARHGAP29 GPNMB NCOA2 KIF6 NRCAM RALYL NUP214 SIK3 CUBN TESK1 SPAG6 SLC5A5 CNNM4 NCOR1 HEYL KMT2D HOOK3 CLCA2 DHX32 TP53BP1 | 2.16e-05 | 1074 | 254 | 24 | C0006142 |
| Disease | Prostatic Neoplasms | TET2 SSX2 KMT2C JUP VPS52 UCP3 MPO NCOA2 COL5A1 EFEMP2 COL5A3 SLC5A5 NCOR1 KMT2D USO1 LRP2 HERPUD1 | 2.81e-05 | 616 | 254 | 17 | C0033578 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.71e-05 | 144 | 254 | 8 | EFO_0004611, EFO_0020943 | |
| Disease | triglycerides to total lipids in small HDL percentage | 3.73e-05 | 72 | 254 | 6 | EFO_0022336 | |
| Disease | alpha-amylase 1 measurement | 5.10e-05 | 9 | 254 | 3 | EFO_0801371 | |
| Disease | cholesterol in large HDL measurement | 6.77e-05 | 80 | 254 | 6 | EFO_0021900 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 7.23e-05 | 10 | 254 | 3 | C1631597 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 7.38e-05 | 2 | 254 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 7.98e-05 | 206 | 254 | 9 | EFO_0004612, EFO_0020947 | |
| Disease | Sezary Syndrome | 8.05e-05 | 27 | 254 | 4 | C0036920 | |
| Disease | red blood cell density measurement | TET2 DENND4A HIVEP1 EXOC3 MAST2 MEIS1 PRKD3 DPEP2 MITF CC2D2A TRIM48 EP400 PKP4 SIK3 CPS1 MTFR1L TG ZNF106 MYO15A DNAJC5B | 8.51e-05 | 880 | 254 | 20 | EFO_0007978 |
| Disease | risk-taking behaviour | TET2 RELN HIVEP1 TBC1D5 UBQLN4 TENM2 PHF21A BPTF ARID5B CC2D2A SHISA6 LCORL REV3L LRP4 RGS17 CTNNA1 NRG3 NPAS4 | 1.24e-04 | 764 | 254 | 18 | EFO_0008579 |
| Disease | autoimmune thyroiditis (is_implicated_in) | 1.31e-04 | 12 | 254 | 3 | DOID:7188 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | TET2 ELOA2 PSMA2 LAMA1 F5 KMT2C DLC1 GPNMB PHIP MPO DNAH3 NRCAM CUBN DUSP21 WIF1 LRP2 CDH7 | 1.38e-04 | 702 | 254 | 17 | C0009402 |
| Disease | neutrophil count | TET2 DENND4A HIVEP1 UBQLN4 ZFP57 ZCCHC2 MAST2 CIC GABPB2 TELO2 DPEP2 FAM186A PKD1 MITF ZPBP2 PXYLP1 ZNF282 MPO IPO7 DOCK8 WDR27 SIK3 CPS1 LRP4 NAIF1 CHTOP | 1.67e-04 | 1382 | 254 | 26 | EFO_0004833 |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.69e-04 | 60 | 254 | 5 | EFO_0022237 | |
| Disease | triglycerides in small VLDL measurement | 1.82e-04 | 61 | 254 | 5 | EFO_0022145 | |
| Disease | triglycerides in small HDL measurement | 1.97e-04 | 62 | 254 | 5 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 1.97e-04 | 62 | 254 | 5 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.97e-04 | 62 | 254 | 5 | EFO_0022339 | |
| Disease | triglycerides to total lipids in IDL percentage | 2.13e-04 | 63 | 254 | 5 | EFO_0022329 | |
| Disease | HDL cholesterol change measurement, response to statin | 2.20e-04 | 3 | 254 | 2 | EFO_0007805, GO_0036273 | |
| Disease | Hashimoto Disease | 2.20e-04 | 3 | 254 | 2 | C0677607 | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 2.20e-04 | 3 | 254 | 2 | DOID:0060206 (implicated_via_orthology) | |
| Disease | epidermolytic hyperkeratosis (implicated_via_orthology) | 2.20e-04 | 3 | 254 | 2 | DOID:4603 (implicated_via_orthology) | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 2.20e-04 | 3 | 254 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | triglyceride measurement, alcohol drinking | 2.20e-04 | 99 | 254 | 6 | EFO_0004329, EFO_0004530 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | ACACB BPTF MTARC1 SIK3 CPS1 ZNF106 EEPD1 DOCK7 HERPUD1 TP53BP1 | 2.33e-04 | 291 | 254 | 10 | EFO_0008317, EFO_0020946 |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.46e-04 | 101 | 254 | 6 | EFO_0004530, EFO_0007878 | |
| Disease | body weight | TET2 RELN HIVEP1 BCL6 ZZEF1 PHF21A BPTF PKD1 PXYLP1 BAIAP2 CACNA1B ZCCHC12 NRCAM LCORL RALYL CHD8 HUWE1 CPS1 BCDIN3D NCOR1 EYS USF3 ZNF341 CDH7 | 2.53e-04 | 1261 | 254 | 24 | EFO_0004338 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.73e-04 | 103 | 254 | 6 | EFO_0008595, EFO_0020944 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.76e-04 | 243 | 254 | 9 | EFO_0004612, EFO_0020944 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 2.84e-04 | 67 | 254 | 5 | EFO_0008595, EFO_0020946 | |
| Disease | triglycerides in very small VLDL measurement | 3.04e-04 | 68 | 254 | 5 | EFO_0022144 | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.26e-04 | 69 | 254 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | NR2C2 TENM2 MEIS1 A2ML1 ARID5B COL5A1 CASP8AP2 KIF6 DDX12P LAMA5 TIPARP TG EYS USO1 CTNNA1 | 3.38e-04 | 619 | 254 | 15 | EFO_0003923, EFO_0004531 |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | PABPC4 MTARC1 TRIM48 SIK3 CPS1 HEYL EEPD1 DOCK7 HERPUD1 TP53BP1 | 4.04e-04 | 312 | 254 | 10 | EFO_0004612, EFO_0010351 |
| Disease | waist-hip ratio | EPHB2 TET2 BCL6 ZZEF1 MEIS1 BPTF DLC1 PKD1 ARID5B CIBAR2 TAB1 PHIP SHISA6 COL5A1 LCORL COL5A3 SIK3 BCDIN3D MTFR1L PHC1 CEMIP WDR11 RGS17 | 4.17e-04 | 1226 | 254 | 23 | EFO_0004343 |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | PABPC4 MTARC1 TRIM48 SIK3 CPS1 HEYL EEPD1 DOCK7 HERPUD1 TP53BP1 | 4.35e-04 | 315 | 254 | 10 | EFO_0004612, EFO_0008591 |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | PABPC4 MTARC1 TRIM48 SIK3 CPS1 HEYL EEPD1 DOCK7 HERPUD1 TP53BP1 | 4.35e-04 | 315 | 254 | 10 | EFO_0004574, EFO_0004612 |
| Disease | Job Syndrome | 4.38e-04 | 4 | 254 | 2 | C3887645 | |
| Disease | very low density lipoprotein cholesterol measurement | 4.51e-04 | 260 | 254 | 9 | EFO_0008317 | |
| Disease | non-small cell lung carcinoma | 4.80e-04 | 75 | 254 | 5 | EFO_0003060 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | MYO5B PABPC4 MTARC1 TRIM48 SIK3 CPS1 HEYL EEPD1 DOCK7 HERPUD1 | 5.04e-04 | 321 | 254 | 10 | EFO_0004612, EFO_0004639 |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 5.08e-04 | 43 | 254 | 4 | EFO_0022290 | |
| Disease | severe acute respiratory syndrome, COVID-19 | EPHB2 RELN TENM2 FBXO47 NCOA2 VENTXP1 P2RY8 TG EYS SLC15A1 PDE4DIP RGS17 | 5.43e-04 | 447 | 254 | 12 | EFO_0000694, MONDO_0100096 |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | PABPC4 MTARC1 TRIM48 ZNF311 SIK3 CPS1 HEYL EEPD1 DOCK7 HERPUD1 | 6.24e-04 | 330 | 254 | 10 | EFO_0004529, EFO_0004612 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 6.92e-04 | 276 | 254 | 9 | EFO_0004612, EFO_0020943 | |
| Disease | Myelodysplastic syndrome | 7.26e-04 | 5 | 254 | 2 | cv:C3463824 | |
| Disease | MYELODYSPLASTIC SYNDROME | 7.26e-04 | 5 | 254 | 2 | 614286 | |
| Disease | C-reactive protein measurement | PABPC4 CCDC168 ZCCHC2 ZZEF1 MEIS1 PHF21A BPTF PKD1 LCORL MAP3K8 ATP9A BCDIN3D NCOR1 HEYL ZNF106 SETD5 EEPD1 DOCK7 RGS17 CTNNA1 HERPUD1 TP53BP1 | 8.04e-04 | 1206 | 254 | 22 | EFO_0004458 |
| Disease | phospholipids:total lipids ratio | 8.28e-04 | 227 | 254 | 8 | EFO_0020946 | |
| Disease | esterified cholesterol measurement | 8.67e-04 | 128 | 254 | 6 | EFO_0008589 | |
| Disease | cognitive inhibition measurement | 9.05e-04 | 50 | 254 | 4 | EFO_0007969 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 9.05e-04 | 50 | 254 | 4 | C0023453 | |
| Disease | choline measurement | 9.40e-04 | 130 | 254 | 6 | EFO_0010116 | |
| Disease | phospholipids in very small VLDL measurement | 9.75e-04 | 51 | 254 | 4 | EFO_0022300 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 9.75e-04 | 51 | 254 | 4 | EFO_0022302 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 1.05e-03 | 52 | 254 | 4 | C0023452 | |
| Disease | Global developmental delay | 1.06e-03 | 133 | 254 | 6 | C0557874 | |
| Disease | cholesteryl ester transfer protein measurement | 1.08e-03 | 6 | 254 | 2 | EFO_0009133 | |
| Disease | polycystic ovary syndrome (implicated_via_orthology) | 1.08e-03 | 6 | 254 | 2 | DOID:11612 (implicated_via_orthology) | |
| Disease | Thyroid Dyshormonogenesis 1 | 1.08e-03 | 6 | 254 | 2 | C1848805 | |
| Disease | triglycerides in HDL measurement | 1.13e-03 | 53 | 254 | 4 | EFO_0022317 | |
| Disease | breast cancer (is_marker_for) | 1.16e-03 | 185 | 254 | 7 | DOID:1612 (is_marker_for) | |
| Disease | total lipids in medium VLDL | 1.21e-03 | 54 | 254 | 4 | EFO_0022153 | |
| Disease | triglycerides in medium HDL measurement | 1.21e-03 | 54 | 254 | 4 | EFO_0022321 | |
| Disease | hypertrophic cardiomyopathy | 1.22e-03 | 92 | 254 | 5 | EFO_0000538 | |
| Disease | Neurodevelopmental Disorders | 1.28e-03 | 93 | 254 | 5 | C1535926 | |
| Disease | triglycerides in very large HDL measurement | 1.30e-03 | 55 | 254 | 4 | EFO_0022324 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.30e-03 | 55 | 254 | 4 | EFO_0022234 | |
| Disease | Profound Mental Retardation | 1.33e-03 | 139 | 254 | 6 | C0020796 | |
| Disease | Mental deficiency | 1.33e-03 | 139 | 254 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.33e-03 | 139 | 254 | 6 | C0025363 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | N4BP2L1 PABPC4 MTARC1 TRIM48 SIK3 HEYL DOCK7 HERPUD1 TP53BP1 | 1.33e-03 | 303 | 254 | 9 | EFO_0004612, EFO_0020945 |
| Disease | urinary metabolite measurement | 1.35e-03 | 245 | 254 | 8 | EFO_0005116 | |
| Disease | triglycerides in LDL measurement | 1.39e-03 | 56 | 254 | 4 | EFO_0022320 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 1.39e-03 | 56 | 254 | 4 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 1.39e-03 | 56 | 254 | 4 | EFO_0022251 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.48e-03 | 57 | 254 | 4 | EFO_0022284 | |
| Disease | peripheral vascular disease | 1.51e-03 | 7 | 254 | 2 | EFO_0003875 | |
| Disease | Developmental regression | 1.51e-03 | 7 | 254 | 2 | C1836830 | |
| Disease | Phencyclidine Abuse | 1.51e-03 | 7 | 254 | 2 | C0031391 | |
| Disease | Phencyclidine-Related Disorders | 1.51e-03 | 7 | 254 | 2 | C0236742 | |
| Disease | Goiter | 1.51e-03 | 7 | 254 | 2 | C0018021 | |
| Disease | triglycerides in IDL measurement | 1.58e-03 | 58 | 254 | 4 | EFO_0022149 | |
| Disease | total lipids in medium HDL measurement | 1.58e-03 | 58 | 254 | 4 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 1.58e-03 | 58 | 254 | 4 | EFO_0022267 | |
| Disease | intraocular pressure measurement | RELN DCN STOX2 DLC1 FAM186A ARID5B TRIM48 COL5A1 PCLO RALYL ZNF106 LRP4 | 1.65e-03 | 509 | 254 | 12 | EFO_0004695 |
| Disease | cholesterol in medium HDL measurement | 1.68e-03 | 59 | 254 | 4 | EFO_0021903 | |
| Disease | phospholipids in VLDL measurement | 1.68e-03 | 59 | 254 | 4 | EFO_0022301 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.68e-03 | 59 | 254 | 4 | EFO_0022248 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQTLVQPSVANRAMR | 196 | Q99569 | |
| ASGNVRSLPSQQMVN | 291 | Q9H2P0 | |
| IIQAMVDGQPSLQQV | 206 | O43414 | |
| LMNRSPATGQNVNIT | 61 | Q96L91 | |
| TAAGQQVQMIPAVTA | 3081 | Q96L91 | |
| LRQKSPSDQQMIGQA | 131 | Q6ZTR7 | |
| PSDQQMIGQAETRVQ | 136 | Q6ZTR7 | |
| QPVTLSSVQQAQIMG | 371 | Q9HCK8 | |
| LNCLGMEPVQTANSR | 2376 | Q9HCK8 | |
| VMRSLGQNPTEAELQ | 36 | P0DP25 | |
| QPSSTMGQVGRQLAI | 66 | Q16611 | |
| SNPQAARLLQMQTQG | 161 | Q96DY2 | |
| IRGDMPNQIVQILTQ | 226 | Q7Z5W3 | |
| VNTANVTLGPQLMEV | 196 | Q14956 | |
| SMVELQDPNSNRIAQ | 156 | A8K2U0 | |
| MAIRIPTSNPQTSNN | 976 | A2A2Z9 | |
| IRNMVNFRNVVDGQP | 406 | P0DTE7 | |
| IRNMVNFRNVVDGQP | 406 | P0DTE8 | |
| LEQDLQQVMVSGPNL | 31 | P53365 | |
| QQVMVSGPNLNETSI | 36 | P53365 | |
| IRNMVNFRNVVDGQP | 406 | P0DUB6 | |
| MIPSAQQEIGRSQQQ | 1331 | Q9ULJ7 | |
| VESMCRLQQQASGRP | 61 | Q9NUS5 | |
| IRNMVNFRNVVDGQP | 406 | P19961 | |
| TQQGLMVASPAQTLN | 1006 | O75179 | |
| VGTPADLVNVRMQND | 116 | Q9UBX3 | |
| RANSLVMQPISQSQA | 371 | Q7L7V1 | |
| MACNIPNQRQRTLST | 1 | Q9UF47 | |
| QQVMTQIIRGQPVST | 2216 | Q12830 | |
| TGEQRQSKLSPQMQV | 2361 | Q12830 | |
| VMRSLGQNPTEAELQ | 36 | P0DP24 | |
| QTINNGRAAAPVVMD | 701 | Q9UKL3 | |
| PMSAANISIAARQQN | 746 | Q00975 | |
| NRPIDIQATTMDGVN | 356 | Q8WUJ3 | |
| MTAVGVQAQRPLGQR | 1 | Q8WXS4 | |
| SLGLPRQQLQLMAQD | 301 | Q9UER7 | |
| SRPQGSNQLMNTLRN | 241 | Q96JC9 | |
| RVNINTATPAQLMSV | 136 | Q7L9B9 | |
| VGITVMIENLVNNPN | 351 | Q6P1M9 | |
| EQQRLPLGNGIQTMS | 171 | O43918 | |
| PLGNGIQTMSASVQR | 176 | O43918 | |
| GCVATQNPKRIQRMN | 1136 | Q7Z401 | |
| NARVIAGQPLDINMA | 76 | Q86SE5 | |
| QTGLLDPGMLVNIQQ | 236 | P49116 | |
| SRDLPQAMGQLQQQL | 76 | Q9ULR5 | |
| QITGNNIMLVASQPA | 1436 | P98160 | |
| PMRNQAQISFIQDIG | 571 | O75943 | |
| IPAGLQSMNQALQRR | 21 | Q3YEC7 | |
| GQLVPGNRMTSTNLA | 366 | Q6ZRI8 | |
| MRKRQQSQNEGTPAV | 1 | Q9UGC6 | |
| TLQITPAMAQGINAD | 766 | Q5JSJ4 | |
| NMSVLIPDRTNVGDQ | 106 | Q7Z3E1 | |
| NQNLRMNAQGGPIVE | 241 | Q15011 | |
| NATLQMLRNPAIAVA | 11 | Q86VZ1 | |
| LANGRMPTVLQCVNV | 156 | Q9Y5K2 | |
| VQPMIDQSNRAVSQG | 331 | O00470 | |
| ADVNLPAAQLQIAMG | 596 | O00763 | |
| QRNTSINMQLPSRET | 561 | P56975 | |
| VAGMRALPANAILNQ | 386 | Q13310 | |
| VMTTNIRSARGNNPN | 621 | Q8IYF1 | |
| RQMSGAQIKIANPVE | 306 | Q15365 | |
| MNAAPGVDLTQLLNN | 306 | P13645 | |
| PGRVLDNAMNSNVTV | 2961 | Q8NEZ4 | |
| VINQEGNMVTARQEP | 96 | Q5VT66 | |
| GVSSLNLVNPMAIEN | 2846 | Q5T1H1 | |
| ANNVQRVMAQALGIP | 286 | Q643R3 | |
| DVNVTGMQSSPLQGR | 201 | O43292 | |
| MVAPGNVRVNVVNST | 846 | Q92823 | |
| GPRMVVTNLLTRNQD | 381 | Q0VAK6 | |
| VERNQLMQLPRSIGN | 111 | Q6UWE0 | |
| NISGNEIQRLPQMLA | 156 | Q6UWE0 | |
| AREMTLQATALQQQP | 2466 | Q9UKN7 | |
| TPMQQRICNLLGEAT | 126 | Q69YI7 | |
| ELLQQMNVGTRPINL | 211 | P35908 | |
| GPLDLTVNRMQEQNT | 211 | Q8N3X6 | |
| CSRAGQVLPVSIQMN | 571 | Q96KR4 | |
| NSQDIQIQVMGRVPT | 396 | P40123 | |
| GRPTSTREQMQQVLE | 336 | P0DPD6 | |
| QFDPNLGIRQAMTSI | 1131 | Q5VYK3 | |
| SGILLNMVITPQNGR | 106 | P41279 | |
| AEGNISQPVLMDINA | 36 | Q6Q8B3 | |
| AQMNQIQSVEGQPLA | 976 | P29323 | |
| LLPGRGQVMVVQNAS | 4736 | Q9Y6V0 | |
| VTSAQPQNMSRRAQG | 521 | O15031 | |
| PQNMSRRAQGEVQLT | 526 | O15031 | |
| LQCVTGPQATRGQML | 946 | O15031 | |
| DMEQIPQVLNQVSGQ | 846 | O95373 | |
| FSMQQRQALAQISLP | 686 | P05164 | |
| NGLNQMIVIELGTNP | 171 | P07585 | |
| QRSQVPAVSQVMGSL | 206 | A6NFA0 | |
| QQLTAQLNLMALPGE | 411 | H3BV12 | |
| GQRPTIAMVTAINSQ | 151 | Q96BD5 | |
| QQVALGISENMAVPL | 616 | Q6ZMV9 | |
| NKSVLRPAVTNGMSQ | 1131 | Q7LBC6 | |
| SPSTSNNIPLMRVVQ | 391 | O94806 | |
| VQPMIDQSNRTGQGA | 321 | Q99687 | |
| ALRRQMASQAPAVNT | 1096 | P35658 | |
| VTSQMNSVQLDGLRP | 501 | P54753 | |
| GQEGQLSQMARPLST | 21 | Q9NQ87 | |
| IVMQRNASVPNLRGS | 96 | Q9H019 | |
| QQMAQQVRFPTDTLQ | 336 | Q8N8V2 | |
| SMEGISNILQSGIRQ | 316 | Q99689 | |
| SGRRSPQNVMAQQKV | 1306 | Q6ZVL6 | |
| QMSRGPVSVTQLDQS | 1686 | Q6ZVL6 | |
| QIAMTTNLLSQPRGI | 2626 | P98164 | |
| QSSMQLRTPGDQILN | 521 | O75110 | |
| DLPTRNVNLAQSVVM | 171 | Q9BXC1 | |
| SRPDVVLQGNQMSIT | 1731 | O15230 | |
| VQPVIGISQRVRMNS | 146 | Q96FE7 | |
| MGPVSRQEAQTRLQG | 16 | P46109 | |
| GTMQPVSDFRQQLLA | 621 | Q96FC9 | |
| QAQEGQLTTQGLMPL | 431 | Q86VS8 | |
| QMATLPQASNLATRI | 1516 | Q7Z6Z7 | |
| LQAIDPQSNIRNMVA | 16 | O95402 | |
| GSPQLVAAVVRTMQN | 181 | P14923 | |
| PTMARAVVVNAAQLA | 186 | Q02978 | |
| IDGNNVNNPVMLLDT | 1946 | P78509 | |
| GSNNMVAVVVNNPVR | 2016 | Q96RW7 | |
| MASGTTQQADIPRQQ | 1391 | O60244 | |
| VQPTLISSMAQSQGQ | 71 | P53539 | |
| LPRATANSQVMGSAN | 391 | Q9NQ84 | |
| PRSTLVMGIQQENRQ | 61 | Q9NVK5 | |
| IQQISQLAQGMDRPF | 636 | Q8IUM7 | |
| ATRTNIGIQEFMPLQ | 246 | Q52LW3 | |
| VPLLAAASGQNRMTQ | 11 | P0C5K6 | |
| SINLQQPRMATERGN | 36 | O60494 | |
| RQIVIQNENTMPRVT | 11 | Q9UM11 | |
| LGGRPTSTREQMQQV | 406 | P0DPD8 | |
| QGSIMTEPQITQVNQ | 576 | Q15067 | |
| LMNPNIASVQTNEVG | 461 | P31327 | |
| FAQAVGRNIANPTAM | 311 | O43837 | |
| LARPSAVVQMGQNVS | 326 | Q8N6C5 | |
| VLLAAARQAQTMQAP | 351 | Q8IZ08 | |
| ARQAQTMQAPSLLSV | 356 | Q8IZ08 | |
| APRMSNQGIAVLNNF | 336 | Q53GT1 | |
| TGVRPEVARTNQNIM | 316 | Q9P2K1 | |
| LQMVLQGSVGTTVNQ | 2021 | Q96N67 | |
| QLSVQPMVIAGQTAN | 801 | Q8NF50 | |
| GQSARAIMAQLPQEQ | 666 | P35221 | |
| DAMVGPLRNTIDINN | 1051 | O14981 | |
| SQVAVMQRELTALQP | 2691 | Q8TD57 | |
| SQITNNIDPVGRIQM | 31 | P62873 | |
| QQARDLQNRSGAMSP | 181 | Q13158 | |
| VIAGGTMQPVSNFRQ | 636 | Q92771 | |
| AVSQSRNEMGIPQQT | 646 | Q15398 | |
| PQRDQTQRQQEPMAS | 226 | Q8NI99 | |
| GPMVSAQESQAQAIL | 536 | P20908 | |
| PQASRLNNIVNRSMT | 441 | P41182 | |
| LRGTVMQAPAVRQVN | 1076 | Q6VMQ6 | |
| NLVRMRNQSLGQSAP | 136 | Q6P0Q8 | |
| MASRINTNFTLIPNQ | 1 | Q5MNV8 | |
| SPSTQGLQEQARALM | 66 | Q9H4A9 | |
| QVNLTIQGLRAMDTG | 111 | P16410 | |
| VMRSLGQNPTEAELQ | 36 | P0DP23 | |
| ATPGRLNDLQMNNSV | 351 | Q86TM3 | |
| SSPNQQRTPQVIGVM | 211 | O95639 | |
| QRTPQVIGVMQSQNS | 216 | O95639 | |
| GQSQPSALDTLVQAM | 926 | Q86VF2 | |
| VPATGQFMRIQNVGQ | 1231 | Q7Z589 | |
| QQRQPEASIGSMVSR | 391 | Q96AY2 | |
| NQNQPSVGMVISVQA | 281 | Q8NDH2 | |
| DMPQLRSVKAQGQQQ | 436 | Q8NDH2 | |
| TVLAMESQNPSQVGR | 451 | Q9ULB5 | |
| QAQALGMPLTTQQAQ | 1391 | A6NE01 | |
| QEITLTPQQAQALGM | 1431 | A6NE01 | |
| QALGMPLTAQQAQEL | 1441 | A6NE01 | |
| TAVQRVAGMLQRPDQ | 11 | O60645 | |
| TNNQTLRLLMGQGLP | 151 | Q5T4B2 | |
| QINNVSAMLVLARPV | 391 | O95967 | |
| VQNGPSSTVQMQRLP | 91 | P53992 | |
| GALEIQPDQMQTVNA | 316 | P46059 | |
| PTNQIRLTNVAVVRM | 6 | Q9Y3A5 | |
| GPQEENLMIQSIGNI | 2171 | P21817 | |
| AGAQGLTQTPTEMQR | 21 | Q9BUN1 | |
| AQAVLQQTQLSMKGP | 466 | P25940 | |
| FNNNTVRMINSPVGN | 161 | Q9H596 | |
| MAFQTQAGAQIPIER | 2851 | P98161 | |
| SNQGKDPMIRNQRSV | 126 | Q3MIW9 | |
| TLQVVQGQPLMVQVS | 51 | P23511 | |
| AIARQQPNGVDFTMV | 391 | Q8TAK5 | |
| NLRGNLTNMETNGVV | 376 | P32754 | |
| ECSRIPMGQAVNSQL | 3011 | Q5T011 | |
| QVQQIILVSPMGVSR | 156 | O60763 | |
| IVGTLQRTQRNMNSG | 6 | Q8IWZ4 | |
| QGKINQMATAPDSQR | 141 | Q9UQE7 | |
| PQNIETLQNAGVMSL | 31 | O75602 | |
| MGSISQQNIRSEQRP | 171 | Q9NWS0 | |
| MAAQRRSLLQSEQQP | 1 | Q15750 | |
| GRNNTMIRAVQPGET | 466 | P12259 | |
| NMLQGATELVAEPNR | 171 | Q15345 | |
| RATMAQNENVVVQPV | 586 | P30414 | |
| PNTAILQSSLVMGEQ | 556 | Q14872 | |
| LQRIMETDPLQQGQA | 526 | Q9NVN8 | |
| QVSINNTAVMQRLAP | 551 | P25391 | |
| QQMQVNLRPDVARGL | 1621 | O75376 | |
| ASPINRIVQISGNSM | 1001 | Q9NWH9 | |
| QLGRSQPGMLQQELS | 81 | Q86VE3 | |
| QSGPSQSRMRQIGTN | 116 | Q86VE3 | |
| GNQVQRPQMTFGRLQ | 91 | Q99909 | |
| VMTRQNQIPTEDGSR | 251 | Q86TU7 | |
| GSQMQLQLGRVTRVQ | 266 | Q9C0A6 | |
| QAGTAMNISVPQVQL | 416 | Q9Y2K2 | |
| AARGTLPLNVIQMSQ | 336 | Q6ZSJ9 | |
| LMEAQCRQQTQPGFI | 136 | Q9Y4R8 | |
| QQPAIITSIMGNGRR | 1206 | Q9NT68 | |
| PILNQTIGRMQRATE | 351 | Q8TE99 | |
| EATQGQQQQLRGMVP | 621 | O95785 | |
| QQQQLRGMVPIVLVA | 626 | O95785 | |
| VTQQPMRVGNQVNVT | 256 | Q9P1W8 | |
| ISALNGNRINVPMVR | 716 | Q96QB1 | |
| RTGQPLPQSIQQAMR | 1086 | Q96QB1 | |
| NQMGRTLPELITQFN | 321 | Q5JPH6 | |
| IPERAVQLMQQVASN | 236 | Q9UQB8 | |
| VQLMQQVASNGATLP | 241 | Q9UQB8 | |
| AAQLPMSIRINSQAS | 486 | Q99856 | |
| MQRGIFTSPTNSQQL | 1126 | Q14865 | |
| QALQELTQMVSGPAS | 371 | Q96RK0 | |
| NNTLNNAMPVRLQVG | 441 | Q7LFX5 | |
| AQQMENRPSVQAALK | 56 | Q9Y3Y2 | |
| TANGNIQMNAPRKSV | 716 | Q9UQC9 | |
| PQQGTIVGMRLASCN | 41 | Q6P4Q7 | |
| VLQQQGSQERSPGLM | 56 | Q96A22 | |
| PGQRQTLQSQVMNIG | 996 | Q15596 | |
| SASQVVGLNQMVPQI | 871 | Q9C0B9 | |
| ILGMEISAPSQQRQQ | 2011 | Q6P2Q9 | |
| ADLTRAVNALPQNMT | 1546 | Q7KZ85 | |
| ACNRSNSQPRIMQVI | 566 | Q7Z2D5 | |
| MNVQSVRSTDPQRLG | 486 | Q8N1B4 | |
| TIPNERTMQLLGQLQ | 526 | Q8N1B4 | |
| GTLPNIMRNAIVNCA | 181 | P55916 | |
| RNSVTVQVMALNPSR | 386 | Q9BYN7 | |
| LVGMDPEQASVTNQN | 296 | Q5W0Z9 | |
| RTEGPMAQNQASVLK | 251 | Q9NU63 | |
| MQQRVPVSQTPAINV | 86 | O75030 | |
| DVMRALGQNPTNAEV | 91 | P14649 | |
| QLIPQMGVTSSGLNQ | 616 | Q8WWQ0 | |
| PSVQQRSQMRAPQCV | 2581 | O60673 | |
| NDPNRGNQVERPQMT | 86 | Q16385 | |
| VMPAGSQQVSVRFQV | 256 | O95210 | |
| MLVGGPRQVLTLAQN | 211 | Q92911 | |
| RNQVERPQMTFGSLQ | 91 | O60224 | |
| LGTSAAQAMPASQRQ | 746 | Q9P2F5 | |
| NPTMINKGTRSNANI | 116 | Q02086 | |
| ALPEMVRALSAQQQT | 686 | Q8TB22 | |
| TTNVQMSIIRSNAPG | 206 | Q9H0E3 | |
| MQFRVPGDQTSTIIQ | 666 | P24821 | |
| QALNGPLRSNMIQTI | 1956 | P24821 | |
| NRIPEGSQGMAEQLQ | 721 | Q9HBJ7 | |
| PTAQLVQRVASVMQE | 106 | P25787 | |
| NGTAIIQLPSKRQMQ | 221 | Q5T653 | |
| VMNSEGNTILQTPQN | 156 | Q9Y5W5 | |
| QQNVGMNLTRTATPA | 346 | P78364 | |
| QVIQMAQPVGSAVNS | 531 | Q68DE3 | |
| LTSRGLEQQMVSQPS | 1631 | Q68DE3 | |
| PSNRGNTLREVQLMN | 91 | Q15569 | |
| SILMNPAQDGEVQLS | 566 | Q12888 | |
| PGNVQILNMVTRQGA | 111 | Q5SRD1 | |
| RNQIGPGCQTQTMVQ | 6 | Q86UU1 | |
| TVPFKSGQRQIQANM | 686 | O43548 | |
| AVIPDVVQMRQQAFG | 86 | Q9BQ87 | |
| QPSGRLQANQSLNRM | 761 | Q13472 | |
| MTQAQAVSAPGILNR | 221 | O43670 | |
| SVRQLGSNMVVPQAK | 1226 | O43149 | |
| QVNRTNMTPSDPLQT | 186 | Q8N680 | |
| VGQQDLMINNPLSQD | 131 | Q92609 | |
| MQIQQGLQTLATEAP | 456 | Q9UHD9 | |
| ALVRAQQCPSMGQSL | 391 | A2RRH5 | |
| TPNNMGLVRNELQLV | 536 | Q9BZH6 | |
| NRNDIQTAGTMTVPL | 486 | Q6N021 | |
| TNPRAMQALLQIQQG | 461 | Q9NRR5 | |
| LLRPMVEGQSQQFSV | 421 | P01266 | |
| VSQPGMNSQLEQREG | 81 | Q15937 | |
| AGQPENMDSQQLVSL | 3796 | Q9Y4A5 | |
| SPGAQQLINMVRFQQ | 36 | Q499Y3 | |
| NEPQQMVSPSNSLRA | 886 | Q9H2Y7 | |
| VNIVGLANTNMAPQV | 2496 | P15822 | |
| RKANIMTEPQNSQGR | 151 | Q96NJ3 | |
| PRNVQILNMVTRQGA | 111 | O14925 | |
| TGNNRINITETGQLM | 81 | Q6X784 | |
| MQFVSTRPQPQQLGI | 1 | Q9UDV7 | |
| EVMRVLQATNPNLSV | 96 | Q6PEW1 | |
| LDGRPMNIQLVTSQI | 171 | Q86V81 | |
| QGNLPQADITLMSQA | 46 | Q5JNZ3 | |
| DLATAQVQPLQNMTG | 41 | Q96T25 | |
| GSQMVSNIPQAEVNV | 596 | Q9BYP7 | |
| VAPGMNRQQVSLLAQ | 3446 | O14686 | |
| MPTVGQLRAQLQGVL | 4191 | O14686 | |
| MDIIVVSPQRQTGTN | 1601 | O75096 | |
| GASQEQRQNLGLMTP | 216 | O00160 | |
| SGAVQTMEPLIQAAQ | 1731 | Q9ULV0 | |
| AMRNGISPIIIDNTN | 106 | Q5TBK1 | |
| GRDSLMSQAPISNQQ | 686 | Q5VU43 |